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ABSTRACT
Incidence and Clinical Predictors o f Risk Factors for Inappropriate Shock in Patients with
Implantable Cardioverter-Defibrillators
Shu-Ling Lo
Sudden cardiac death (SCD) is a major unresolved medical problem worldwide.
Although Implantable Cardioverter-Defibrillators(ICD) are highly effective in diagnosing 
and treating life threatening arrhythmias, inappropriate shock therapy (1ST) occurs in 
approximately 5-20% of ICD recipients. 1ST results in pain, anxiety, induction of 
ventricular arrhythmias, decreased battery longevity, and even death. Researchers 
studying clinical predictors o f 1ST have drawn findings based on single case studies with 
small samples or with out-dated data. This study filled this gap by describing the 
incidence and co-existing clinical predictors o f 1ST.
Methodology
This descriptive, retrospective study analyzed the incidence and clinical predictors o f 1ST 
in ICD adult recipients by utilizing a five-year retrospective review ICD interrogation 
records and medical charts at a university hospital.
Results
During a mean follow-up period o f 24.1 ± 16.2 months, 20 out o f 119 ICD recipients 
received appropriate shock, and 1ST occurred in 13(9%) out of 119 ICD recipients. A 
total o f 16 1ST experiences occurred among these 13 patients. Eight subjects received 1ST 
for atrial fibrillation (AF)/atria tachycardia or sinus tachycardia/normal sinus rhythm, two 
for double counting, two for lead problems, and one for drug interaction. O f these, 12 out 
of 98 men received 1ST. One out o f 21 women received 1ST. Using Chi-square and 
logistic regression analysis, results showed only AF as a significant predictor (p=.002 vs 
0.001) and remains the main cause of 1ST. Although the variables o f age, gender, NYHA 
class LVEF and structural heart disease showed no significant relationship. Trigger 
events occurred during clinical interventions and were noted in this study.
Conclusion
The clinical characteristics o f patients prone to 1ST should be carefully considered when 
planning clinical interventions. With the rapid expansion o f this patient population, a 
multisite expanded longitudinal study is indicated to confirm the results seen in this 
initial descriptive study.
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CHAPTER I 
STUDY PROBLEM AND ITS SIGNIFICANCE 
Background
Sudden cardiac death (SCD) is defined as death from abrupt, unexpected circulatory 
arrest occurring within a short period, generally less than an hour, following the onset o f 
acute symptoms (Jeanne, Poole & Bardy, 2004). SCD occurs in about 450,000 people in 
the United States each year (American Heart Association, 2005). It also affects a 
significant number o f people in many other countries (Connolly, Gent, Roberts, 2000; 
Spector, 2005). SCD is a major unresolved public health problem in the U.S. and 
throughout the world. It is often attributed to untreated, life threatening, ventricular 
arrhythmia (Bardy, 2004). Attempts to prevent SCD with antiarrhythmic agents have met 
with little success and may even increase mortality (Cardiac Arrhythmia Suppression 
Trial II Investigators, 1992). Some nontypical antiarrhythmic agents (e.g., 13 blockers), 
have demonstrated a reduction in arrhythmic deaths by reducing the ischemic burden. 
Revascularization is most often used as the first line o f intervention for the reduction o f 
sudden death risk in ischemic patients (Spector, 2005). However, the limited efficacy o f 
SCD prevention and the failure o f  resuscitation from out-of-hospital cardiac arrest 
renders SCD a significant problem. The development o f the implantable cardioverter 
defibrillator (ICD), which almost instantly detects and treats life - threatening ventricular 
arrhythmia has in recent years revolutionized the treatment o f SCD (Mirowki, Reid, 
Mower, Watkins, & Gott, 1980).
1
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The advent of the ICDs has resulted in a significant decrease in the rate o f SCD 
from ventricular tachycardia (VT) and ventricular fibrillation (VF) in specific populations 
(Moss, Hall, Cannom, Daubert, Higgins, Kiel, et al., 1996). With the advent of 
monitoring capabilities from the ICD, there has been a tremendous change in the 
prevention of sudden arrhythmia death (Moss, Zareba, & Hall, 2002; Naccareli, 2004).
The ICD is responsible for sending electrical signals that satisfy programmed criteria and 
is highly effective in reverting such rhythms back to normal (Klein, Auricchio, Reck, & 
Geller, 1999). An appropriate shock was defined as a spontaneous ICD discharge that 
terminated with such clinical symptoms as palpitations, nausea, dizziness, light­
headedness, or syncope (Schreieck, Zrenne, Kolb, Ndrepepa, & Schmitt, 2001). The ICD 
functions by delivering shocks in response to electrical signals that satisfy 
preprogrammed criteria, and it is highly effective in reverting VT and VF to normal 
rhythms (Klein, Auricchio, Reck, & Geller, 1999). Clinical trials have demonstrated that 
the ICD is superior to medication in prolonging the lives o f individuals with a history o f 
prior or inducible, sustained, ventricular arrhythmia (i.e., VT longer than 30 seconds; 
Antiarrhythmics Versus Implantable Defibrillators [AVID], 1997; Kuck, Cappato, Siebels, 
& Ruppel, 2000). With the completion o f multiple randomized clinical trails, ICDs have 
emerged as the dominant therapy for the secondary and primary prevention o f SCD 
(Bardy et al., 2005, Connolly et al., 2000; Kuck et al.; Moss et al., 2002; Sheldon, 
Connolly, Krahn, 2000). In addition to the secondary and primary prevention o f SCD, 
ICDs have an emerging indication for dilated cardiomyopathy (DCM) (Bansch, Antz, 
Boczor, Volkmer, Tebbenjohanns, Karlheinz et al., 2002). The current "Practice 
Guidelines o f  Indications fo r  Implantable Cardioverter - Defibrillator Therapy”
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(Gregoratos, Abrams, Epstein, Freedam, David, & Hayes et al., 2002) is based on the 
clinical trails (Appendix A) developed by the expert panel of ACC/AHA/NASPE in 2002 
(Appendix B). Along with the therapies for the secondary and primary prevention of 
SCD, the ICD indications expanded to chronic heart failure and DCM (Abraham, 2003; 
Guidant Atrial Features Guide, 2001). A substantial increase in the implantation of ICDs 
is expected because o f these expanded indications.
Statement o f the Problem 
ICDs are accurate and effective in the diagnosis and treatment o f VT and VE 
However, inappropriate shock therapy (1ST), defined as shocks occurring in the absence 
of life threatening ventricular arrhythmias, occurs in approximately 5% - 20% of ICD 
patients (Grimm, Flores, & Marchlinski, 1993; Lauria, Glikson, Brady, Lexvold, 
Rasmussen, Hodge, et al., 2001, Rosenqvist, Beyer, Block, Den Dulk, Minten, & 
Lindemans, 1998; Theuns, Klootwijk, Simoons, & Jordaens, 2005). Inappropriate therapy 
shocks are hazardous because the consequences o f 1ST are severe and have been reported 
in many studies (Messali, Thomas, Chauvin, Conmel and Leenhardt, 2004; Steinbrook, 
2005).
Impacts o f  Inappropriate Shock
Physiological Impact
Patients have described the sensation of an inappropriate shock as a pain similar 
to being punched in the chest or kicked by a horse (Thomas, 2001). 1ST, apart from 
being painful, may also cause myocardial damage, as documented in animal and human 
studies (Epstein, Kay, Plumb, Dailey, Peter, & Anderson, 1998). Due to 1ST,
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proarrhythmia is also a frequently reported event (Pinski & Fahy, 1995). Pinski and Fahy 
reported on death from 1ST, and Messali, Thomas, Chauvin, Coumel, and Leenhardt 
(2004) also recorded deaths in their research, with the rate varying from 0.4% to 8%. The 
risk for proarrhythmia appeared to be most common in situations with fast 
superventricular rhythms with a concomitant increase in sympathetic discharge, rate- 
related disease in ventricular refractoriness, or myocardial ischemia (Pinski & Fahy,
1995).
Psychological Impact
Although the ICD is a lifesaving device, living with the possibility of receiving a 
defibrillating shock at any time can be emotionally devastating. One small study 
(Dougherty, 1995) and a national survey (Sears & Conti, 2002) found that patients 
receiving ICD shocks, along with their families, experienced more anxiety, anger, 
depression, and stress than patients and families who had not received shocks. A study o f 
57 patients (Luderitz, Jung, Diester, Mameros, & Manz, 1993) found that patients who 
had experienced five or more shocks from an ICD had a higher state o f anxiety than those 
who experienced fewer than five shocks. In another study o f the impact of ICD therapy 
(Godemann, Butter, Lampe, Linden, Schlegl, Schulth, et al., 2004), the results 
demonstrated that, in patients who have two or more ICD discharges annually, the 
incidence o f panic disorders and agoraphobia were higher than in those who only 
received a single ICD discharge annually. Patients’ level o f psychological symptoms was 
correlated with fear o f ICD malfunction, particularly anxiety, depression, and fear o f 
death (Dougherty, 2004). The manner o f how one’s quality o f life was affected by ICD
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shock(s) has been reported in several studies (Sears, Eads, Marhefka, 2002; Carroll & 
Hamilton, 2005).
Economic Impact
Other major negative impacts o f 1ST include the induction o f ventricular 
arrhythmias and a decrease in life longevity o f battery caused by frequent shocks (Lin, 
Dixit, Russia, & Hsia, 2004). As the results of these effects, the replacement of already 
expensive ICDs will require additional costs. In addition, the fees o f diagnostic 
procedures, treatments, and frequent clinical visits’ fees must be paid as well. The 
unfavorable cost effectiveness resulting from ISTs ultimately may become a financial 
burden for the health care system.
Predisposing Clinical Characteristically Factors Are Not Well Known 
Many inappropriate ICD discharges are caused by supraventricular arrhythmias 
that are triggered by a problem with the ICD device, or that occur at a time when the 
environment interferes with the ICD (Pinski & Trohman, 2002; Rinaddi, Simmon, 
Bostock, Elliot, & Gill, 2004). However, patients and clinicians report that inappropriate 
shocks still occur with no identifiable causes (Champagne, Geelen, Philippon, & Brugada, 
2005; Glikson, 2004). The literature review demonstrated that, in the majority o f patients 
who are at risk for an 1ST, the clinical predictors o f ISTs are not well known. In addition, 
neither the timing nor the circumstances under which an 1ST occurred (e.g., exercise, 
dehydration) were correlated to occurrence o f inappropriate therapy (Healy, Ngarmukos,
& Rosenthal, 2002). Many case studies, consisting o f only one to four patients, provided 
in-depth information about the incidence of inappropriate shock (Healy, 2002; Messali, 
2004; Peters, 1998). However, these findings cannot be generalized due to limited data
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(Bums & Grove, 2004). As a result, there exists no exhaustive list o f what may or may 
not affect an ICD. The multitude o f variables makes it impossible to know how a device 
will respond to various sources o f interference. Misinformation and outdated information 
perpetuated within the medical community cloud these issues.
Current Status o f  Intervention Programs 
Many respected nursing researchers have explored the impact o f ICD therapy, 
including interventions to promote the quality o f  life for ICD recipients and their families 
(Carlesson, Olesson & Hertervig, 2002; Shea, 2004; Sneed, 1997; Vitale & Funk, 1995). 
Educational intervention programming related to psychological aspects has also been 
discussed extensively (Dougherty et al., 2004; Higgins, 1990; Sneed, Fench, & Michel, 
1997; White, 2002). However, care practices are likely to have evolved that do not 
encompass the physiological elements. Few studies have provided information regarding 
the experience o f shock itself or have made distinctions between appropriate shock and 
inappropriate shock. Recently, an educational program developed by Dougherty et al. 
made suggestions for the educational intervention o f ICD recipients. Their suggestions 
were based solely on the number o f  shock events and the level o f pain experienced, 
which might not accurately reflect the seriousness o f a shock event. For example, a 
patient could feel pain when he/she experienced a “phantom shock” in which no true 
shock occurred but the patient claimed to feel pain). Conversely, a patient might not feel 
pain due to his/her loss o f conscious from a high-energy shock. In a recent nursing care 
journal discussing the issues o f patients with ICDs, Dunbar (2005) intended to discuss all 
areas of concerns from psychosocial aspect. However, it was not clear whether the 
author intended to give information to prevent an inappropriate shock or address
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appropriate shock in the nursing care o f patients with ICDs. The author stated that, 
“Known predictors o f inappropriate shock are history o f atrial tachyarrhythmia and 
recurrent ventricular tachycardia that have triggered appropriate therapy”(p.297). 
Moreover, there are still many other risk factors that could trigger inappropriate shocks 
and appropriate shocks. Hence, without sufficient published information, it would be 
difficult to provide effective educational programs. O ’Brien, Langberg, Valderrma, 
Kirkendoll, Romeiko and Dunbar (2005) investigated patients and families involving 
ICD storms, where patients experience two or more appropriate and/or inappropriate 
shocks within 24 hours. This study provided great insight into the effects o f an ICD storm 
and the management o f shocks; however, intervention for preventing the occurrence o f an 
inappropriate shock event remains an unsolved problem. Appendix C summarizes the last 
five years o f nursing research related to care of the ICD recipients.
Future Technological Considerations 
As ICDs become more complicated, the incidence o f inappropriate shock is likely 
to increase (Rinaddi, Simmon, Bostock, Elliot, Bcknall, & Gill, 2004). In addition, there 
has been a corresponding increase in the number and complexity o f patients seen in 
follow-up visits after ICD implantation. This increased visitation volume demands that 
clinical practice create alternative methods to safely and effectively monitor these 
patients. Recently, the internet-based remote monitoring service has allowed clinicians to 
remotely manage their patients' ICDs and chronic diseases. The network is comprised of 
a patient monitor, a secured server, and clinician and patient websites. Under clinical 
direction, patients interrogate their ICDs at home and transmit data to a secure server via 
standard telephone lines (Joseph, Wilkoff, Dresing, Burkhardt, & Khaykin, 2004).
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Patients have become critical consumers o f health care and are frequently using the 
internet as a resource for their health concerns and treatment options. Cardiovascular 
nurses have a unique opportunity to assist patients using this modality. Web pages 
provide interactive patient education, including behavioral interventions, for risk 
reduction management in ICD therapy. This study serves as an exemplar for how 
cardiovascular nurses can work with these valuable tools for patient care.
The Role o f Cardiovascular Nurses in the Management of Inappropriate Shock Therapy
from a Physiological Aspect 
The nursing profession plays an important role in the delivery o f health services, 
particularly for cardiovascular patients. Nurses are responsible for recognizing “cue 
complexes,” or syndromes, and for providing prompt emergency treatment (e.g., cardiac 
resuscitation). Nurses also provide appropriate information to the ICD recipients and 
their families regarding the diagnosis or plan o f therapy following physician-nurse 
appraisal (Roger, 1971). One goal o f advanced cardiovascular nurses is to integrate 
technology with patents’ everyday lives. Cardiovascular nurses can play a pivotal role in 
providing optimal care for ICD patients. Through effective nursing interventions utilizing 
current guidelines and updating information in a multidisciplinary forum, nurses can 
develop realistic, scientifically-based guidelines for ICD patients. To date, no study has 
systemically analyzed clinical conditions as risk factors predisposing patients to an 
inappropriate shock, and the phenomenon remains relatively unexplored. As nurse 
scientists, advanced cardiovascular nurses are taking leadership roles in major 
interdisciplinary organizations and need knowledge and skills to contribute in a
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1ST in patients with ICDs 9
competitive, ever-evolving field. Therefore, it is imperative to investigate the clinical 
characteristics o f ICD patients that may be predictive o f inappropriate shock in a broad 
population.
Purpose o f the Study 
The overall purpose o f this study was to describe the incidence o f appropriate and 
inappropriate shock occurrence and to investigate the clinical predisposing factors for an 
inappropriate shock in a group o f ICD recipients treated at a university medical center in 
Southern California during the period from July 2000 to May, 2005. The specific aims 
were as follows:
Specific Aim # 1
To describe the incidence o f appropriate and inappropriate shock occurrence in a 
group o f ICD recipients who visited the university medical facility between July, 2000 
and May, 2005 for emergent and routine follow-up visits.
Specific Aim # 2
To describe the relative risk relationships between age group and 1ST, gender and 
1ST, heart disease severity and 1ST, structural/ non-structural heart disease and 1ST, and 
the history o f atrial fibrillation and 1ST.
Specific Aim # 3
To describe the frequency o f ISTs in a group o f ICD recipients by risk factors (e.g., 
atrial fibrillation, lead problems, double counting) and the frequency and proportion o f 
each risk factor associated with an 1ST.
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Specific Aim #4
To investigate significant correlations between clinical factors and an 1ST, and, 
when taken in combination, to reveal any clinical predictability for the incidence of an 
1ST. Clinical factors analyzed include demographic characteristics, history of previous 
underlying heart disease, ejection fraction, and medications taken at the time of the 1ST.
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CHAPTER II 
REVIEW OF LITERATURE 
Inappropriate shocks from ICD therapy occur in a combination of events 
involving the interference of the patient, device and environment. Regarding the causes 
o f  1ST, it is imperative to understand the foundation it is built upon. For this reason, the 
author has scrutinized the pathways that lead to 1ST.
This section begins with a review relevant arrhythmias of implantable 
Cardioverter-deflbrillator. The concepts of reentry and defibrillation are discussed, 
because they play important roles in the events o f 1ST. The author then proceeds to 
discuss the development o f ICD, its multiprogrammable features and the function o f this 
modem device. This section concludes with the significance o f interrogation concerning 
ICD in follow-up visits.
The Relevant Arrhythmias o f Implantable Cardioverter -Defibrillator Therapy: 
Supraventricular Arrhythmias 
Supraventricular Tachycardia.
Supraventricular tachycardia (SVT) is a rapid, regular heart rate, where the 
heartbeat ranges from 150 to 250 beats per minute in the atria. The condition can be 
caused by a number o f factors, or it can occur spontaneously. As a result, the heart beats 
abnormally fast and the oxygen supply to the brain is reduced. Some people experience 
no symptoms, yet others may experience dizziness, syncope, shortness of breath, pale 
color, chest tightness, and chest pain (Ganz, 2002).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1ST in patients with ICDs 12
Atrial Fibrillation
Electrical signals in the atria are fired in a very fast and uncontrollable manner. 
Atrial signals create a pattern o f rapid and chaotic beating that starts at 350 beats per 
minute and ranges higher. Instead o f a single electrical signal followed by coordinated 
atrial contraction, there is quivering o f the atrial muscle. Not all signals are conducted 
through the AV node. Ventricular rates may vary from 100 to 180. Atrial fibrillation (AF) 
may occur in a sustained manner or may occur episodically (Woods, Froelicher, Motzer,
& Bridges, 2005).
Ventricular Arrhythmias
The two major types of the ventricular arrhythmias are ventricular tachycardia (VT) 
and ventricular fibrillation (VF). VT is a regular heartbeat arising in the ventricles. 
Ventricular fibrillation occurs when the ventricles go out o f control, quivering and 
beating ineffectively, thereby stopping the pumping action. If a more normal rhythm is 
not restored promptly—within three to five minutes— the patient will suffer brain and 
heart damage and will die (Kastor, 2000; Woods, Froelicher, Motzer, & Bridges, 2005).
Ventricular Tachycardia.
Ventricular tachycardia occurs when the ventricles produce impulses that make the 
heart beat too quickly. With this disorder, the heart tries to beat 150 a minute or more.
The heart does not fill with enough blood between beats to meet the body's needs. 
Symptoms include a pounding sensation, dizziness, and sometimes fainting occurs 
(Kastor, 2000). There are several categories that VT falls under. Please see Table 1.
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Table 1
Ventricular Tachycardia Defined by Category
Category 1 
Duration / Duration o f Tachycardia
Transient also called 
unsustained or nonsustained 
(NSVT)
Beats are no longer than 30 seconds, with a minimum of 3 
consecutive ventricular beat and without cardiovascular 
deterioration.
Sustained in which the 
paroxysms last (SMVT)
More than 30 seconds, with cardiovascular deterioration, 
requires immediate treatment to prevent cardiovascular 
collapse.
Incessant Most o f the time.
Category II
Electrocardiographic Appearance / QRS Form
Monomorphic ventricular 
tachycardia
Each of the QRS complexes has identical or nearly 
identical.
Polymorphic ventricular 
tachycardia (also called 
Torsade de Point, TdP)
The morphology (form) o f the QRS complexes change
A particularly rapid, dangerous form o f VT that often 
occurs as a result o f certain medications or in patients with 
congenital Long QT syndrome.
Category III
The Presence or Absence of Heart Disease/ Examples
With heart disease most often coronary or cardiomyopathic
Without structural heart 
disease or idiopathic.
Long QT syndrome, Brugada syndrome, short QT 
syndrome.
Source: Modified from Kastor, 
Sunders, p.343. 
Ventricular Fibrillation
. A. (2000). Arrhythmias. (2nd). Philadelphia : W. B.
Ventricular fibrillation (VF) is a chaotic heart rate resulting from multiple areas o f 
the ventricles attempting to control the heart's rhythm. VF sometimes can occur 
spontaneously, but generally it is caused by heart disease, or when VT has persisted too 
long. When the ventricles fibrillate, they cannot contract normally, hence, they cannot 
effectively pump blood. The instant VF begins, effective blood pumping stops. VF 
quickly becomes more erratic, resulting in sudden cardiac arrest or sudden cardiac death. 
This arrhythmia must be corrected immediately via shock from an external defibrillator
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or an ICD. The defibrillator can stop the chaotic electrical activity and restore normal 
rhythm (Ganz, 2002; Kastor, 2000).
Mechanisms o f Fibrillation and Defibrillation 
The Role o f  Reentry
The available clinical and experimental evidence suggests that instability in VT 
leading to the degeneration o f the VT into VF is a phenomenon o f re-entry, which is a 
disorder of impulse conduction (Singer, 1994). The restitution hypothesis suggests a 
mechanism for the development o f instability in re-entry that may explain the 
predisposition for degeneration to fibrillation (Adgey, Spence, & Walsh, 2005; Spector, 
2005).
Re-entry is a continuous electrical activity in which each wave re-circulates to 
produce the next wave. For activation waves to propagate continuously, two paths for 
conduction separated by unexcitable tissue are required. Activation must spread around 
one side of the unexcitable tissue allowing the other side time to recover from 
inactivation in order to re-excite the tissue when the wave front returns. Tissue refractory 
periods limit re-entry: the conduction time around the circuit must be greater than the 
refractory period o f each component o f the circuit. Therefore, decreased conduction 
velocity or a decreased refractory period facilitates re-entry by decreasing the likelihood 
that the activation wave front will encounter its own refractory tail, ending the 
tachycardia (Woods, Froelicher, Motzer, and Bridges, 2005)
In clinical practice, re-entrant circuits can occur in two circumstances. First, a 
fixed re-entry is the site o f an anatomic conduction block that resulted from scar tissue
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and frequently occurs in the setting of ischemic cardiomyopathy (Adgey, Spence et al., 
2005).
The second circumstance during which functional re-entry may occur is in the 
absence of anatomic obstacles. In this instance, the circuit path is determined by tissue 
refractoriness. Factors leading to the correct conditions that favor such re-entry 
mechanisms include increased heart size through hypertrophy or dilatation, drugs that 
alter the length o f the refractory period, and areas o f cardiac disease. A group of 
transiently unexcitable cells (i.e., secondary to refractoriness) creates an obstacle to the 
conduction around which a circuit can form (Adgey, Spence et al., 2005).
The Electrophysiological Concepts o f  Ventricular Defibrillation 
The mechanism of ventricular defibrillation has been extensively investigated over 
many decades. However, the definite mechanism o f defibrillation is still unclear and 
many hypotheses have been proposed. The most influential was the critical mass 
hypothesis. First proposed by Garrey inl914 (Spence, 2003), it was supported by several 
other electrocardiologists. Garrey found that a fibrillating heart would no longer fibrillate 
when the myocardial mass decreased into small pieces (Adgey, Spence et al., 2005). The 
studies from Schunder, Stoekle, Gold, West, & Denniston (1973) and Miroski, Mower, 
Gott, Brawley, & Denniston (1973) showed that successful defibrillation could occur 
when low energy shocks were delivered though a transvenous catheter. This result 
suggested that the shock might need to defibrillate only the critical mass of the ventricles 
to get a successful outcome. In 1975, Zipes, and his colleagues provided further 
validation for this idea by demonstrating that the chemical depolarization o f a critical 
mass of ventricular myocardium (-75% ), using selective infusion o f potassium chloride
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into the left coronary artery, would successfully abolish ventricular fibrillation. Therefore, 
if a sufficient voltage potential gradient could be generated by a shock to halt the 
fibrillation activation fronts in the myocardium, defibrillation could occur (Adgey,
Spence et al., 2005).
Historical Development o f the o f Defibrillator 
Development of practical defibrillators began in the 1920s with response to an 
increasing number o f electrical shock accidents and deaths. In 1947, Beck et al. 
performed the first successful human defibrillation using specially designed internal 
cardiac paddles to resuscitate a 14-year-old boy who had become pulse-less during 
elective chest surgery. In 1956, Zoll et al. performed the first successful human external 
defibrillation using a 15-amp AC current that produced 710 volts applied across the chest 
for 0.15 seconds. In 1961, Alexander, Kleiger, and Lown first described the use of AC 
current for terminating VT. Work by Lown et al. in the early 1960’s demonstrated the 
superiority and safety o f DC over AC for defibrillation. Ambulance-transported Belfast 
physicians first performed successful pre-hospital defibrillation in 1966. Defibrillation by 
emergency medical technicians (EMTs) without the presence o f physicians was first 
performed in Portland, Oregon, in 1969 and was reported in 1972. (Bocka, 2005)
The Implantable Cardioverter Defibrillator 
In the 1960s, Mirowski (1985) conceived o f the idea of an automatic implantable 
defibrillator. The first ICD was implanted in a young woman as a prophylaxis against 
SCD in 1980. The U.S. Food and Drug Administration approved the device in 1985.
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The earliest devices weighed up to 300 grams, had a battery life o f three years, 
and were implanted in the subcutaneous layer o f the abdomen with epical screw-in leads, 
and were sutured to the pericardium (Wolfe, Kosinski, & Grubb, 1998). A second 
generation of devices, developed in the mid-1980s, did not require thoracotomy, but used 
a transvenous defibrillating lead. These second generation ICDs employed cardioversion, 
were programmable, detected ventricular arrhythmias better, and delayed electrical 
therapy. In the 1990’s, the third generation ICDs had multiple features, tiered therapies, 
enhanced programmability, and increased sophistication, as well as being designed to 
target energy delivery. Additionally, these advanced devices weighed less than 40 
milligrams and had a battery life o f eight years (Fetzer, 2003).
Components o f  Current ICDs
The current ICD consists o f a pulse generator and one or more leads. An epoxy 
resin header at the top of the generator connects pacing and defibrillation electrodes 
(DiMarco, 2003; Zipes, Libby, Bonow, & Braunwald, 2005).
The newer models provide a daily rhythm history with as many as 150 certain 
therapy events stored in their memory. The devices that store a graphic image of a 
patient’s arrhythmia, called an electrogram (EGM), are ready for interrogation by an 
external analyzer. However, if  events go beyond the capacity o f storage, the oldest 
rhythm would be discarded and the newest would be stored instead (DiMarco, 2003).
An ICD battery usually functions between four and eight years, depending on the 
number of shocks and/or the pacing it sends. When the battery runs down, a new ICD 
must be implanted (DiMarco, 2003; Fetzer, 2003; Zipes, Libby, Bonow, & Braunwald, 
2005).
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The leads are responsible for capturing the electrical activity that goes toward 
internal sensing, provide a site for pacing and defibrillating. Recent technological 
improvements in electrode design have led to improved features. The transvenous leads 
have decreased the amount of energy required to defibrillate. This decrease in energy has 
rendered the need for the larger epicardial patches and electrodes rendering sternotomy 
incisions obsolete. Therefore, these transvenous leads are now accepted as a standard 
(Seidl & Senges, 2003). Currently, the following models are available: (a) a single 
chambered, ventricular-only device that is usually placed in the right ventricle; (b) a dual­
chambered atrial and ventricular device with leads placed in the right ventricle and atrium; 
and (c) a biventricular ICD, whose leads are attached in the right atrium, the right 
ventricle and the left ventricle. These techniques help the heart beat in a more balanced 
way and are specifically used for patients with heart failure.
Functions o f  Implantable Cardioverter-Defibrillator
The ICD has three major functions: monitoring, detecting and delivering. The 
ICD program monitors the R wave o f the electrocardiogram and counts the number of 
QRS complexes per minute on a beat-to-beat basis (Fetzer, 2003). The ICD determines 
when the ventricular rate exceeds the programmed limit. Many ICDs have a VT zone 
(e.g., 150-200 beats per minute [bpm]) and a VF zone (e.g., > 200 bpm). When the ICD 
has detected the ventricular rate and QRS morphology abnormalities that exceed its 
programmed limits, the program triggers the antitachycardia pacing therapy (ATP).
When the heart beats too fast, a series o f small electrical impulses are delivered to the 
heart muscle to restore a normal heart rate and rhythm for VT, or delivers a shock to 
terminate VF (Clemo & Ellenborg, 2001; DiMarco, 2003).
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When the shock program has been initiated, the device can be programmed to 
deliver a first shock from a minimum of 1 joule to a maximum of 41 joules, depending on 
the energy level required; traditionally starting at 10 joules. The charging time can take 
0.1 to 7 seconds. After delivering the first shock, a 5 to 25 second delay is programmed to 
allow the ICD to detect any continuing dysrhythmia and recharge. Second, third, fourth, 
and fifth shocks are delivered at the maximum energy level if needed. Newer ICD models 
can be programmed for six shocks, and some will deliver a maximum of eight shocks.











Appropriate Shock vs Inappropriate Shock 
Appropriate shock is defined as an ICD delivered discharge (shock) at the presence of VT or VF
Inppropriate shock is defined as an ICD delivered shock at the absence of VT or VF, usually with no preceding symptoms.
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Interrogation o f  the ICD
The interrogation procedure is typically done every three months in a specialized 
pacemaker/ICD follow-up clinic. A cardiac electrophysiologist, assisted by a trained 
technician or senior cardiovascular nurse, performs the procedure. Interrogation is also 
performed as the device approaches elective replacement or in response to symptomatic 
events (e.g., shocks).
During ICD interrogation, a “wand” is passed over the device and is attached to a 
programmer for communicating by means o f electromagnetic coupling. Thus, the 
electrophysiologist is able to determine what electrical therapies have been experienced. 
The interrogation process checks lead integrity and battery status. Based on the revealed 
information, the device can be adjusted to optimize detection and therapy parameters. 
Most ICDs record the patients’ electrocardiographic tracing at the time of arrhythmia 
detection. This information can be analyzed at follow-up visits to determine the nature of 
the arrhythmia and the efficacy o f the electrical therapy that was given (Groh & Foremn, 
1998).
An implantable defibrillator, prescribed for people whose hearts beat dangerously 
fast, operates differently from a pacemaker. When a defibrillator detects a fast heart rate, 
it delivers electrical therapies to restore a normal rhythm. Depending on the patient's 
condition, these therapies can begin mildly and become progressively stronger as needed 
(ATP). The highest energy therapy is called defibrillation, and it provides treatment 
similar to defibrillation paddles used by medical personnel (Fetzer, 2003). Over 250,000 
defibrillators have been implanted worldwide since 1985 (Metronic, 2005).
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Review o f Literature on Inappropriate Shock 
The ICD has achieved a preeminent role in the treatment o f life-threatening, 
ventricular arrhythmias. The most common arrhythmias-related complaint among ICD 
patients is the subjective feeling o f shock. The variant causes o f inappropriate shock 
therapy remains a major clinical problem and the contributing factors remain unclear. 
Weber, Boecker, Block(1996) reported that the causes of 1ST are many, including: AF, 
the most frequent cause o f  1ST; lead over sensing due to lead failure; sinus tachycardia; 
problems with environmental interference; and other unknown factors. Studies in which 
the incidence o f ISTs has been examined have documented single, multiple, or repetitive 
shocks from a variety causes in ventricular ICDs. However, studies investigating atrial 
ICDs that cardiovert atrial fibrillation with a slow ventricular rate are no longer available 
and are beyond the scope o f this review. Therefore, the topic o f  atrial ICDs will not be 
addressed.
Overall Factors Contributing to 1ST 
The first large scale study reviewed by Grimm et al. (1992), retrospectively 
analyzed the incidence and causes o f  documented cases o f spontaneous 
electrocardiography (ECG), and ICD discharges in the absence o f VT and VF in 241 
patients. During the follow-up period (24 ± 20 months), records o f electrogram storage 
demonstrated that 54 o f 241 patients (22%) received a total o f 132 spontaneous ICD 
charges in the absence o f VT or VF. The researcher further found that the most frequent 
cause o f these ISTs was AF with rapid ventricular response (n = 30 patients). ISTs caused 
by lead problems occurred in eight patients. The rest o f events o f 1ST were caused by 
generator malfunction VVI programming, and by T-wave oversensing.
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Nunain, Roelke, Trouton, Kim, Sosa-Suarez, and Brooks (1995) performed a 
descriptive study examining the problem(s) o f third generation ICD therapy. One 
hundred and fifty-four patients with monomorphic sustained ventricular tachycardia 
(MSVT), VF, or syncope, with inducible VT not suppressed by antiarrhythmic drug 
therapy, and implanted with ICDs, were recruited for the study. In the mean follow-up 
period (15.3 ± 9.7 months), 30 o f 154 patients had non-thoracotomy lead systems. The 
26% rate of 1ST was similar to that reported for an earlier generation (Grimm et al., 1992). 
Thirty-two patients (21% of subjects) received ISTs for either sinus tachycardia or AF 
with rapid ventricular response. In this study, AF remained the primary cause of 1ST, with 
lead problems as the second major cause (n = 3). Nunain et al. acknowledged that the 
success of ATP therapy could reduce the need for shock in the third generation ICD 
device.
Klein, Raitt, and Wilkoff (2003) expanded the number o f  subjects to evaluate the 
incidence and characteristics o f arrhythmia events that triggered ICD therapy in the 
Antiarhythmics Versus Implantable Defibrillator (AVID) Trial. Four hundred ninety-two 
of 1016 participants in this trial were examined. The results demonstrated that 
inappropriate sensing, ICD malfunction, and electrode failure rarely triggered ICD 
therapy in the AVID trial. AF and other sustained ventricular tachycardia (SVT) were 
responsible for attempted therapy in 11 patients and for all 13 treated episodes. Patients 
who received 1ST were slighter younger (63 ± 11 vs. 66 ± 11, p < .05). Since 
approximately one-third o f all patients in the AVID Trial received no syndrome preceding 
the delivery o f the therapy, Klein et al. concluded that clinical or electrophysiologic 
parameters could not predict 1ST accurately.
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A prospective study, conducted by Russio, Nayak, Yerdino, Springman, Tenfeld, 
et al. (2003), examined the occurrence o f ICD shock events in 51 patients (Mf0ii0W-up = 16 
months). 1ST occurred in four patients. Shock therapy was delivered for SVT in four 
patients; one 1ST delivery was related to AF; and one 1ST was related to T- wave 
oversensing. Russio et al. concluded that the low incidence o f 1ST (8%) might be related 
to vigilant device programming. However, the follow-up period utilized in this study was 
limited.
Nanthakumar, Dorian, Paquette, Greene, Edwards, Heng, et al (2003) 
retrospectively analyzed the single chamber ICDs’ recipients with a history o f AF or 
NYHA Class I to identify patients most at risk for receiving inappropriate shock. O f 299 
patients, 261 completed data for analysis. All received ICDs in 1990 using single 
chamber, third generation, tiered device therapy. Results confirmed that 116 o f the 261 
patients (44%) received one or more inappropriate therapies and 73% o f patients received 
inappropriate therapies within 2 years o f receiving their device. The causes ISTs were: (a) 
ST = 58 (50%); (b) AF = 38 (33%); and, (c) noise events = 20 (17%). Seventy-one 
percent o f the patients received shocks within two years o f device implantation. 
Significant predictors o f inappropriate therapy with AF and NYHA Class 1 versus Class 
II- IV. Age, gender, and coronary artery bypass graft (CABG) did not increase the risk o f 
receiving an 1ST. The type o f medications taken upon hospital discharge was also not a 
predictor of events. Nanthakumar et al. supported the suggestion that ICD recipients with 
a previous history o f AF should be considered “at risk” for the occurrence o f 1ST. 
However, the hypothesis that NYHA Class I should not be considered a risk factor, since 
the development o f  1ST remained unsupported.
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Recently, Rinaddi, Simmon, Bostock, Elliot, Bcknall, and Gill (2004) intended to 
assess whether the occurrence o f 1ST would be reduced by the diagnostic enhancements 
of the ICD device. Rinaddi et al. retrospectively analyzed the data from 171 patients over 
17 years of 1ST experience. Based on the records with full data (n =155 patients), results 
showed that 1ST occurred in 22 patients (14%), predominantly for atrial arrhythmias (18 
patients with 1ST for atrial flutter/AF or ST). The occurrence of 1ST in the remaining 
four patients was related to problems with lead fractures. The three independent 
predictors of 1ST identified by these researchers were pre-existing atrial tachyarrhythmias, 
co-existent medication therapy, and a single chamber device. Data also showed dilated 
cardiomyopathy (DCM) and high incidences o f  1ST (50%). AF incidence was also high 
(80%) and in high proportion (78%). Rinaddi et al. stated that the finding o f increased 
coexistent medication therapy was not entirely clear, but might reflect poorer left 
ventricular functioning that is often associated with an enhanced use o f medication 
therapy. Similarly, AF itself might be predisposed to ventricular arrhythmias. As for 
DCM patients, the researchers posited that the high incidences of 1ST were likely related 
to their increased incidence of AF.
Most recently, a prospective study by Theuns, Klootwijk, Simoons, and Jordaens 
(2005). collected clinical and functional variables for each patient. This study evaluated 
whether clinical characteristics could predict inappropriate ICD therapy due to atrial 
tachyarrhythmias. The observations noted in this study were: (1) a history of atrial 
tachyarrhythmias is an independent predictor o f inappropriate therapy; and (2) recurrent 
VT with a C33L >350 ms that triggered device therapy was associated with an increased
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risk for first inappropriate therapy. However, this study was not thorough enough to 
adequately to address the clinical associates.
Individual Factors 
Lead Failure and Related Problems
Dorwarth, Frey, Dugas, Matis, Fiek, Schmoeckel, et al. (2003) retrospectively 
analyzed the incidence and clinical presentation o f transvenous ICD lead failures during 
long-term follow-up and their clinical mode of presentation (n = 261). These patients had 
a transvenous ICD lead systems that were implanted between 1990 and 1998. Seventy 
patients had an implantation site on the abdomen, whereas 191 patients had implantations 
on the pectoral site. Patients who had experienced lead dislodgement were excluded. The 
results demonstrated that 31 o f 261 subjects’ lead malfunction had inappropriate detection, 
with 1ST occurring in 19 of 31 patients who had received 1 to 11 shocks. A high number 
of malfunctions (48%) was observed within the first year after device replacement due to 
battery depletion, with battery depletion occurring after 4.6 ± .07 years. Dorwarth et al. 
recommended that clinicians carefully monitor the lead status in any ICD recipient with a 
transvenous lead for more than four years.
Lead Hyperpolarization
Healy, Goyal, Browing, Robotis, Ramaswamy, Rofino-Nadoworany, et al. (2004) 
did a case study o f another aspect of a lead problem. The patient involved did not 
experience any symptoms prior to being first shocked 16 months after implantation. He 
received the shock at a time when he was climbing the stairs. The initial shock occurred 
after an AF provoked an episode o f VF. This VF was terminated by an appropriate shock,
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but due to lead hyperpolarization and T wave oversensing, the device continued to deliver 
five inappropriate therapies at 30 joules. The mechanism behind this phenomenon was 
unclear, but might have involved an interaction at the lead/myocardium interface at the 
time this patient climbed the stairs. Healey, et al. proposed that the mechanisms for 
proarrhythmic effects o f shock might be caused by an increase in QT dispersion. 
Increasing sotalol from 40 mg bid to 80 mg bid resulted in no further shocks.
Lead Connection: Header and Set Screw-Related Problems
Picket, Saaverdr, Ali, Darbar, and Rottman (2004) reported four cases (i.e., three 
males and one female) o f device malfiinction due to the mechanical failure o f a header 
connection within the a single device family over a limited time. The patient in Case 1 
received one shock on the day after the procedure and 15 shocks occurred three days post 
implantation within one and a half hours. Repeated chest X-rays revealed an incomplete 
penetration o f the right ventricular terminal pin in the header. Two ISTs occurred in 
Patient 3 as the left ventricular lead could not be placed due to increasing dyspnea at the 
time o f implantation. After the device was replaced, no further problems were reported. 
The other two patients, as described by Picket et al., did not receive any ISTs. These 
cases shared a common element o f defective connections between the header post and the 
right ventricular pace/sense terminal pin that required intervention and reconnection. 
Picket et al. posited that such lead connection problems would increase as ICD devices 
became more complex.
Double Counting
Biventricular pacing emerged as a modality for the treatment o f patients with 
heart failure. Combined biventricular pacers and ICDs offered treatment for heart failure
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as well as protection from a sudden cardiac death. Tachycardia detection in first- 
generation biventricular pacemaker-implantable cardioverter defibrillators (BiV ICD) 
occurred through both the right ventricular (RV) and left ventricular (LV) leads, creating 
the potential for inappropriate detection and therapies (Al-Ahmad, Wang, Homoud, Estes, 
and Link, 2004).
Case studies done by Schreieck, Zrenne, Kolb, Ndrepepa, and Schmitt (2001) and 
Liu, Villareal, Hariharan, Rasekh, and Massumi (2003) presented three patients who had 
all received 1ST from biventricular ICD therapy. Al-Ahmad, Wang, Homoud, Estes, and 
Link (2004) performed another study related to the problem o f double counting. Al- 
Ahmad et al. retrospectively analyzed the ICD records from a group o f 23 patients 
receiving biventricular ICD therapy. Within the follow- up period (3.7 ± 2.6 months), the 
results showed that 15 ISTs out o f 33 shocks in five patients were caused by double 
sensing. All episodes resulting in shock occurred because o f sinus tachycardia or a 
supraventricular tachycardia (SVT) higher than the upper-programmed pacing rate o f the 
device with resultant AV conduction and double sensing o f the non-paced ventricular 
depolarization. Al-Ahmad et al. concluded that double sensing o f the R-wave was a 
common and clinically important cause o f inappropriate ICD detection and shock in 
patients with biventricular ICDs. New generation devices with inappropriate detection in 
patients with a first-generation BiV ICD was common and often resulted in inappropriate 
ICD therapy. The most common mechanism o f inappropriate detection was double 
counting, often creating the need for additional procedures. Although devices in which 
tachycardia detection occurred only through the RV lead were now available, RV/LV 
output and double counting should therefore not occur. However, close follow-up o f the
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patients who received a first-generation BiV ICD was necessary (Chugh, Scharf, Hall,
Cheung, Good, Horwood, et al., 2005)
Generator Malfunction Issues
Generator malfunction constitutes another type o f device limitation that could also
cause an inappropriate shock. De Meester and Gilles (2001) reported a case study of 1ST
that related to the ICD malfunction caused by excessive defibrillation o f charge time
>
twice (22 seconds and 19 seconds). Suspected were the gradual decline in battery voltage 
and increase o f battery resistance, and the consequence o f excessive charge time of the 
electric capacitors device was affected by highly variable and ineffective capacitors. 
Therefore, a new generator was implanted. De Meester and Gilles stated that, to avoid 
similar events from recurring, long-term follow-up would be needed to investigate the 
predisposing factors related to a malfunction o f the capacitor’s elements. Because o f this 
potentially serious effect, the manufacturer recommended that ICDs with a charge time 
longer than 14 seconds should be monitored every month. They also suggested that, if  a 
charge time exceeded 60 seconds, an immediate replacement was needed.
Diaphgram Myopotential
Three case studies were reported by Peters, Cooklin, Brockman, Steven, 
Shorofsky, & Michael, (1998). The patient in case 1 had received all asymptomatic 
shocks, which were not triggered by VT. But noise and oversensing were present during 
normal sinus rhythm (NSR) at a moment when the subject was performing the Valsalva 
maneuver. After decreasing the sensitivity in the device, the researchers noted that no 
further shocks occurred in the ensuing month o f follow-up. Peters et al. stated that in all 
three cases, the lead was initially positioned in the right ventricular apex. It is presumed
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that the sensing o f diaphragmatic potentials was directly related to the proximity o f the 
lead to the diaphragm. Peter et al. also recommended that the possibility o f sensed DMP 
should be considered at the time of ICD implantation, especially during ventricular 
pacing, so that the appropriate preventive measures can be taken.
In a larger prospective study, Schulte, Sperzel, Carleson, Dursh, & Erdogan, et al 
(2001) investigated the incidence o f diaphragmatic myopotential (DMP) in a cohort of 
384 ICD recipients from 1991 to 1999. One hundred and thirty-nine nonadequate 
episodes o f arrhythmia due to the oversensing o f diaphragmatic myopotentials were 
observed in 33 out of 384 patients. Eleven out o f these 33 patients had a total o f 32 high 
energy shocks. The majority o f nonadequate arrhythmia detections were during intrinsic 
bradycardia pacing. Electrical lead failure was ruled out in every patient. In 90% of ICD 
recipients provided with programmable maximal sensitivity (n = 16), the reduction of 
maximum sensitivity was effective in preventing further episodes o f nonadequate 
arrhythmia deduction. Schulte et al. recommended that the clinical use o f provocation 
maneuvers to examine the oversensing o f DMP, (i.e., using the induction of DMP 
oversensing to distinguish far field oversensing from electrical lead failure,) can prevent 
an unnecessary surgical lead revision.
Electromagnetic Interference
Anfinsen, Bemsten, Kongsgaard, & Amlie (2002) reported the experience o f an 
ICD recipient who had been implanted with an ICD endocardial lead post MI with VF. 
Two ISTs occurred during an MRI o f the brain in this patient. These authors proposed 
that electromagnetic noise induced during the MRI may be detected as VF and
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subsequently cause 1ST. Anfmsen et al. Suggested that clinicians should consider 
inactivating the ICD before an MRI procedure.
Anifinsen et al. went on to describe EMI occurring in four other patients with 
ICDs. Patient A received one shock while she was cleaning a lamp that connected to a 
230 V 50Hz alternating current. Patient B received an 1ST when he was using a vibrator 
for genital and anal stimulation. Patient C experienced two ISTs while being treated by 
electronic muscle stimulation of the gluteal region. Patient D was using a percussion drill 
when he experienced two episodes o f VF detection during sinus rhythm.
The incidence o f 1ST caused by EMI has been estimated as < 1% per patient/per 
year (Kolb, Zrenner, and Schmitt, 2001). However, some episodes may have gone 
undetected. Thus, the overall incidence o f EMI might be underestimated in the literature. 
The improvement of EMI detection algorithms and advances in lead technology are 
necessary to minimize the risk o f EMI-related 1ST in ICD patients.
The interference between ICD function and the use o f a washing machine was 
documented by Chan and Ho (2005). These authors also reported an instance o f 1ST 
occurring when a subject wore a pair o f cotton gloves to operate a power drill during a 
rainy day. Therefore, Chan and Ho suggested that EMI due to 50 Hz alternating current 
leak could be avoided by giving detailed advice on the handling o f electrical appliances 
to ICD recipients.
Drug Interactions
The concomitant administration o f antiarrhythmic drug therapy remains common 
in patients with ICD. The potential influence o f antiarrhythmic drugs on the defibrillation 
threshold (DFT) is the most significant issue. Class III agents (except amiodarone) can be
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safely administered in conjunction with ICD patients as long as the interaction between 
these therapeutic modalities is monitored (Sergo, & Gerard, 1995).
Due to the psychological impact o f ICD therapy, patients with these devices often 
had symptoms o f anxiety or depression (Dougherty, 1995, Burg, Lampert, Joska, 
Batsford, & Jain, 2004). Pickworth, Votolato, and Raman (2004) reported a 35-year-old 
woman with depression. After implantation, the ICD was tested by delivering a shock on 
the T wave to induce VF. It was not terminated by one 15 joules and one 20 joules shock, 
but terminated by an additional seven external shocks o f 360 joules. After evaluating the 
patient’s drug regimen, a suspected drug to device interaction was discovered between 
Venlafaxine and ICD. After discounting Venlafaxine, an antidepressant with cardiac 
sodium, channel blocking activity was identified as a potential contributor to her elevated 
defibrillation threshold. The ICD was able to successfully defibrillate the patient. Camers 
et al. (2004) suggested that clinicians should be aware o f this potential adverse drug- 
device interaction. Further studies are needed to determine the clinical significance o f 
Venlafaxine therapy in patients with ICDs.
In a case reported by Mcbride, & Klucger (2004), an ICD recipient consumed two 
to three doses of Metabolife 356, a dietary weight loss supplement. The patient received 
four ISTs within 3 days. Device interrogation revealed atrial tachycardia. The patient 
stopped taking Metabolife 356 and took increasing doses o f Sotalol instead. The patient 
remained event free for 18 months. The researcher suspected that the Metabolife 356 
induced atrial tachycardia resulted in multiple discharges. This author proposes that ICD 
recipients concomitantly consuming alternative pharmacotherapy may have an enhanced 
risk o f inappropriate ICD functioning.
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Clinical Characteristics and Other Factors 
Authorities propose that 1ST is most often the result of SVT, lead/device 
malfunction, or oversensing. Other situations leading to the occurrence of 1ST have been 
reported as well (Healy, Ngarmukos, and Rosenthal, 2002).
Healy, Ngarmukos, and Rosenthal (2002) described a case experiencing an 1ST 
associated with improper timing. This 58 year-old man with a history o f ICM underwent 
ICD implantation after having an EPS positive for inducible SMVT. One 1ST occurred at 
one week post implantation. Electrograms revealed that a run o f NSYT had caused the 
ICD to charge. The device appropriately detected the rhythm abnormality and charged. 
However, after charging, a premature ventricular contraction (PVC) with a short coupling 
interval was detected during the second look window and a shock was delivered to the 
patient while in sinus rhythm. Thus, Healey et al. stressed that while algorithms are being 
developed to deliver appropriate therapy for life-threatening ventricular arrhythmias, an 
algorithm that allowed for continued sensing during the charge period might have saved 
this particular patient.
Recently, it has been proposed that a congenital short QT interval is associated 
with an increased risk for arrhythmias and SCD (Schimpf et al, 2003). At present, the 
ICD is the only therapeutic option. Schimpf et al. recruited five patients from two 
unrelated European families who had structurally normal hearts, excessively shortened 
QT intervals, and strong positive family history of SCD. ICDs were placed for primary 
and secondary prevention. Mean QT intervals were 252 ±13ms (QTc 287±13 ms). In the 
follow-up 30± 26 days, Schimpf et al. observed that three o f five patients received ISTs 
for T wave oversensing. After reprogramming their generators o f ICDs by lowering
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sensitivities, no further episodes of 1ST were noted. Schimpf et al. concluded that an 
increased risk for 1ST is inherent, due to the detection of short-coupled and prominent T 
waves.
Idiopathic VF patients had a high recurrence rate o f ventricular arrhythmias. ICD 
prevented SCD from this population; the clinical outcome o f the ICD recipients with 
solely a diagnosis o f Idiopathic VF was lacking. Champagne, Geelen, Philippon, and 
Brugada, (2005) conducted a prospective cohort study (from 1992 to 2000) to examine 
the clinical and electrophysiological characteristics of consecutive SCD survivors from 
idiopathic VF. In this study, after excluding those patients with LQTS, Brugada syndrome, 
right ventricular dysplasia and no history of CAD from 445 ICD recipients, 18 patients 
with idiopathic VF were studied. Six participants had syncope associated with self 
terminated TdP or VF, and 12 subjects survived an episode o f SCD with VF. All of the 
subjects had left ventricular ejection fraction of >50% and a mean age o f 42 (ranging 
from 20 to 70). At the mean follow-up at 41± months, 7 out o f 18 patients received a total 
of 27 shocks, and 8 of 18(44%) subjects received 1ST for a total 21 discharges. The 
causes included AF in l2  o f 21 (57%) episodes in 14 patients (mean age 53±14 years); 
sinus tachycardia in 6 o f 21 episodes in 4 patients (mean age o f 31±13 years); lead 
malfunction 3 o f 21 episodes in 2 patients (mean age unknown); and 6 of 21 episodes in 2 
patients had experienced 1ST from AF. Data also demonstrated that the presence of the 
ICD prevented SCD from idiopathic VF, and only treated the final manifestation of 
unknown diseases. 1ST remained a major concern in this young population.
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Death Events Related to Inappropriate Shock Therapy 
Messali, Thomas, Chauvin, Conmel and Leenhardt (2004) reported that the cause 
o f death of one ICD recipient was related to 1ST. This patient was a 49 year-old man, 
with a 15-year history of NIDCM and an LVEF o f 40%. The patient had a history of two 
cases o f SCD and DCM in his immediately family. A syncopal SMVT was performed in 
1991, with an initial ICD implantation in 1991 in the abdominal site. The generator was 
replaced in 1995 and in 2000, but the same atrial and ventricular leads from the original 
ICD implantation were retained. This patient received six shocks and experienced SCD in 
2000. Data storage o f the fatal event showed an episode o f ventricular oversensing during 
sinus rhythm that was improperly designated as VF because o f some short cycle lengths < 
300ms. This false detection triggered the first shock as well as five subsequent shocks 
within two minutes. The sixth shock induced a true, untreatable VF. Inappropriate shocks 
were delivered due to noise oversensing originating from a ventricular lead with an 
insulation defect. In the interrogation o f the device, it was also revealed that the patient 
had experienced an 1ST nine days earlier due to the same type o f  oversensing and 
multiple NSVT that might have been oversensing in the 12 days before death. Messali et 
al. posited that the event of noise oversensing could be caused by an insulation defect of 
the ventricular lead that was caused by prolonged used and repeated episodes of shock. 
However, other studies have demonstrated that oversensing could have occurred without 
structural lead failure (Dorwarth, et al, 2003). Therefore, the abdominal location and 
coaxial body design may be predictors for long-term structural failure o f the ventricular 
lead. Messali et al. emphasized the need for careful follow-up for patients with ICDs and 
the performance o f interrogation as soon as possible following a shock delivery.
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A recent tragic event occurred, caused by a generator malfunction, to a 21 year- 
old college student with HCM, according to a manufacturer’s report. An autopsy 
revealed no clinically significant pathology beyond a massive left ventricular hypertrophy. 
An ICD was shown to be almost successful in preventing SCD for this young man.
When the manufacturer analyzed the ICD, it was revealed that the device had short- 
circuited internally while trying to deliver high voltage therapy, thereby permanently 
disabling itself. Its memory had been destroyed, making the time of failure impossible to 
pinpoint (Gomic, Hauser, Almquist, Maron, 2005; Steinbrook, 2005). Since this defect 
was not detected at the patient’s previous regular follow-up, the safety and the reliability 
of these life-saving devices triggered a broad discussion. The FDA and Heart Rhythm 
Society will plan to develop the guidelines regarding ICD recalls for manufacture -  
notification standards and will decide when to replace the ICD devices.
Summary and Conclusions 
Despite the rapid evolution o f the ICD device and algorithms designed to reduce 
1ST, the reported incidence of 1ST ranges from 5% to 20% and continues to be a major 
problem associated with the use o f ICD. Although spurious discharges are most 
commonly caused by supraventricular arrhythmias, especially AF, 1ST can be triggered 
by device malfunction, such as lead failure due to battery depletion, and problems related 
to header and set screw connections, double counting, lead hyperpolarization and 
generators. Other factors, such as an oversensing o f diaphragmatic myopotential, 
electromagnetic interference, and interactions between antiarrythmic medications and the 
ICD device are also frequently reported by researchers.
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There is also a growing consensus that structural heart diseases, such as ischemic 
cardiomyopathy and heart failure, which induce the development of AF, contribute to the 
occurrence o f 1ST. In addition, non- structural heart diseases, such as T wave oversensing, 
occurred in patients with short QT syndrome. In some situations, researchers suspected 
the underlying pathology may contribute to 1ST, although the exact nature of the 
relationship o f cardiac pathology to 1ST remains to be explored.
As the above literature review demonstrates, current documentation o f the 1ST 
phenomenon in ICD patients is limited to either case studies or descriptive research 
investigations with mostly small numbers o f subjects. Hence, the knowledge base in this 
area is at an initial stage. While it is a definite limitation that the proposed study is based 
on single-case studies and limited research, it is an appropriate next step in the 
development o f knowledge to examine further the factors which experts suspect may play 
a significant role in contributing to the occurrence o f 1ST. Table 2 refers to the risk 
factors of 1ST in the above studies.
Therefore, given the available evidence regarding the complex factors 
contributing to 1ST, the researcher has examined the incidence of appropriate shock and 
inappropriate shock occurrence and has investigated the clinical predisposing factors of 
inappropriate shock in a group o f ICD recipients from a major medical center located in 
Southern California, which also serves as a tertiary referral hospital.












Inappropriate Shock Therapy Events in ICD Studies with Varying Criteria (Studies are Chorological Order)







Finding (s) R/T 1ST # & Cause(s)
Grimm 
et al /1992
N = 241 Retrospective
Analysis
54 of 241 patients (22%) received a total 132 spontaneous ICD charges to the absence of VT 
or VF
AF RVR: 30 
Magnet misdirect 1
- T wave oversensing 1
- Generator malfunction 1
- Sensing lead malfunction 1
- Lead 1
- Loose set screw 1





• 1ST experience : 36 (28%)Patients
• AF : 32 (21%) SVT (AF or Sinus tachycardia) excess autogain in 2 patients. 





116/261 patients received 1ST
• Causes:
- ST : 58 (50%),
-AF: 38(33%)
- Noise events: 20(17%)
• Predictors of increasing risk of receiving 1ST 
-Previous Hx of AF &
NYHA Fcl received single chamber had high risk of develop 1ST 2-4 =1.3:1 

























• AF and other SVT were responsible for attempting therapy in 22% of patients
• Patient received 1ST slighter younger (63 ±11 vs 66 ±11, p<.03).





• 1ST occurred in 4 patients.
• Causes of 1ST:
- SVA : 4 (8%)
- AF :1





• 1ST : 22 (14%) patients
• Causes -
-Atrial flutter/AF, or ST: 18
- Lead fracture: 4
• 3 Independent predictors of 1ST -
- Pre- existing atrial tachyarrhythmias:
- Coexistent appropriate therapy
- 1ST more common with single chamber than double chamber








(1) a history of atrial tachyarrhythmias is an independent predictor of inappropriate 
therapy and
(2) recurrent VT with a CL >350 ms that triggered device therapy was associated with an 

























Finding (s) R/T 1ST # & Cause(s)
Dorwarth 
et al/ 2003
N = 261 Retrospective
analysis
•31/261 subjects lead malfunction had inappropriate detection 
•1ST occurred 19/31 patients 
•3± (1-11) shocks /patient
X- ray did not show lead fracture in any of patient. Only one case had subclavian crush 
syndrome. S/P the association with battery depletion secondary to old lead ( >4years)
Healey 
et al /2004
N =1 Case Report -Initial 1ST AF
- the subsequently 6 ISTs : T wave oversensing secondary to lead hyperpolarization.
Pickett III 
et al /2004
N = 4 Case report Case 1:15 shocks, -ray revealed incomplete penetration to the RV terminal pin in the header. 
Case 2: no shock although it was found that the terminal pin penetration beyond the set screw 
Case 3: Case 3- 2 ISTs due to the LV lead could not placed because of increasing dyspnea at 
the time of implantation
Case 4 -no shock, terminal pin failed to extend beyond the set screw.
These cases shared a common element of defective connections between the header post and 








Finding (s) R/T 1ST # & Cause(s)
Schreieck 
et al /2001
N = 1 Case study An 1ST due to double detection of ventricular premature beats.
Liu.
et al /2003
N = 3 Cases study Case 1 - one 1ST occurred at 3 weeks after implantation
Case 2 - 4  ISTs occurred during 3 days after 2 weeks implantation.
Case 3 - one 1ST occurred 2 months after implantation
Al-Ahmad 
et al/ 2004
N = 23 Retrospective
study
• 15 1ST /33 1ST episodes in 5 patients
• 7/33 (21.7%) due to double sensing.

























Finding (s) R/T 1ST # & Cause(s)
De Meester 
etal/2001
N =  1 Case study •Two years after implantation Patient suffered from a recurrent syncope. Interrogation of the 
device revealed ICD malfunction caused by excessive defibrillation charge time -22 seconds in 
02/99 and 19 seconds in 03/99. * [manufacturer company recommend charge time of >14 
seconds needs to be follow up every month].
Healy 
et al/ 2002
N = 1 Case study One 1ST occurred at one week after implantation. Electrograms revealed that a run of NSVT 
had ICD to charge. Further inspection revealed that a critically timed PVC during the "second 
look" interval resulted in delivered therapy.







Finding (s) R/T 1ST # & Cause(s)
Peters 
et al /1998
N = 3 Case report Case 1-All several asymptomatic shocks were not triggered by VT. 
noise & oversensing during NSR with deep inspiration & valsalva maneuver.
Case 2 - Received several shocks during AF & multiple arrhythmia detection’s during NSR at 
the time of patient’s defecating.
Case 3 An asymptomic shock was demonstrated during valsalva maneuver
Schulte 
et al/2001
N = 384 Prospective
study
139 non adequate episodes of arrhythmia due to oversensing of diaphragmatic myopotentials 
were observed in 33 patients.
•11/33 patients had a total 32 high energy shock occurred. ***The oversensing of 
























Finding (s) R/T 1ST # & Cause(s)
Groh
et al / 1999
N = 169 Post only 
design
• G1: No any negative response in routine exposure (10-15 seconds)
• G2: 3 subjects experienced inappropriate tachyarrhythmia detection,
• G3: 19/126 showed evidence of oversensing.
• no ICD reprogramming was observed in any of the ICDs in all 3 groups.
Kolb
et al /2001




Case 1, one shock delivered at the time she cleaned the lamp that connect to 230V,
50Hz alternating current.
Case 2, one 1ST when using a vibrator for genital and anal stimulation
Case 3, was treated by electronic muscle stimulation of the gluteal region , EMI lead to
detection of VF and response shock twice.
Case 4, 2 episodes of detectionof VF during sinus rhythm with a normal rate recorded by 
device at the time patients was using a percussion drill.
Anfinsen 
et al /2002
N =  1 Case study 2 ISTs occurred during brain MRI procedure.
Kolb
et al/2002
N = 1 Case study a defibrillation shock without warning symptoms at the moment patient touched washing 
machine.
-Hemodynamic instability.Ruled out sensing problems, No myopotentials;
-Rule out lead and pulse generator malfunction by the evidence of X-ray and interrogation data 
(history). -S/P washing machine was not properly grounded.
Chan
et al /2005
N = 2 Case study Case 1, received one 1ST at the time he operating power drill while it was raining and he wore 
a pair cotton gloves.
Case 2 , received one 1ST while He used his wet hand to touch the old washing 

























Finding (s) R/T 1ST # & Cause(s)
Capoferri 
et al /2004
N =  100 Prospective
observation
study
•19 (19%) patients experienced inappropriate therapy.
12/19 received shock.
• Causes of 1ST : Atrial tachycardia : 8; Sinus tachycardia : 9; T wave oversensing : 2.




N = 1 Case study Venlafaxine, an antidepressant with cardiac sodium channel blocking activity, was identified as 
a potential contributor to patient’s elevated defibrillation threshold.
Mcbride 
et al/2004
N = 1 Case study After consuming 2 to 3 doses of Metabolife 356 (a dietary weight loss supplement), patient 

























Finding (s) R/T 1ST # & Cause(s)
Schim pf 
et al/ 2003












• 3 of 5 patients received ISTs for T wave oversensing.
• Schimpf et al concluded that increased the risk for 1ST is inherent due to the 
detection of short-coupled and prominent T wave.
Glikson 
et al/2004
• N = 82
• stable VT






• 29 (35%) patients had at least one 1ST.
• Hemodynamically stable VT were at considereable risk for subsequent unstable VT
•No description of the events of 1ST. But Glikson et al suggested that degree of the structure 
of heart disease may be as or more important than absence or presence of arrhythmia 











7/18 patients received a total of 27 shocks.
• 8/18 (44%) subjects received 1ST for a total 21 discharges.
• Causes:
-AF: 12/21 (57%) episodes in 14 patients, these patients are older, mean age 53± 14, 
-Sinus tachycardia : 6/21 episodes in 4 patients with a mean age of 31+13 years. 
-Lead malfunction : 3/21 episodes in 2 patients.

























Finding (s) R/T 1ST # & Cause(s)
Messali 
et al /2004
N =  1 Case study 6 shocks on 03/31/00, SCD on 06/29/00.
Data storage of fatal event showed an episode of ventricular oversening during sinus rhythm 
that was designed as VF because of some short cycle lengths < 300ms. This false detection 
triggered the first shock and the five subsequent shocks within 2 minutes, the 6th shock induced 
a true VF that could not be treated because the end of therapeutic procedure had been reached.
Steinbrook
/2005
N=1 Case Study Subject died suddenly, EGM revealed the device had short-circuited internally while 
trying to deliver high voltage therapy, it was permanently disabled. More over, its 












This five-year retrospective study was designed to analyze the incidence of 
appropriate and inappropriate shock and the clinical predictors for inappropriate 
shock in a group o f ICD recipients from a university medical center. This study was 
carried out by reviewing ICD interrogation records and medical charts.
A retrospective method was chosen primarily because the knowledge base 
regarding factors that contribute to 1ST is currently at the descriptive level. It is 
known that the events contributing to 1ST include multiple intrinsic and extrinsic 
factors; however, there are many gaps in current knowledge regarding these clinical 
characteristics and their associations to 1ST. A retrospective method examining 5 
years of patient data was used to capture a variety o f salient factors related to the 
incidence of 1ST. However, this investigation may still have been confounded by 
the possibility o f two problems: first, that the observed time period was too short to 
provide enough information; and second, that rapidly changing technological and 
pharmaceutical developments in devices and treatments may have rendered data 
difficult to evaluate on a cohort basis. With these possible problems in mind, the
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current study was based on data gathered over a five-year period, a moderate 
amount o f time that can provide sound results for analyzing the maximum strengths 
and minimal weaknesses o f a cohort.
Research Setting
This study was conducted at the Arrhythmia Clinic at the University of 
Medical Center in Southern California, USA. This university medical center serves 
the surrounding metropolis and participates as a tertiary, regional, referral center for 
the area's cardiovascular patients. Although the majority of patients were local 
residents at the time of ICD implantation and follow-up, some patients came from 
areas outside o f the region. Therefore, this study has the benefit of being based on 
results from a diverse group o f participants. This hospital has well established 
systems in its Arrhythmic Clinic. Patients who undergo ICD implantation receive 
follow-up care in the clinic, including interrogation procedures to examine the ICD 
device function. Interrogation allows electrophysiologists to determine effects from 
specific forms o f electrical shock therapy that a patient received since the previous 
clinic visit. Lead integrity and battery status are also checked. The ICD device can 
then be adjusted to optimize detection and therapy parameters. Most ICDs record 
the patient’s electrocardiographic tracing at the time of arrhythmia detection. This
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the patient’s electrocardiographic tracing at the time of arrhythmia detection. This
information can then be analyzed at follow-up visits to determine the nature of the
arrhythmia and the efficacy of the electrical therapy that was given.
The cardiac electrophysiologist, along with a trained technician and/or a
cardiovascular nurse, typically conducts an interrogation once every three months.
An interrogation is also conducted as the device approaches elective replacement,
as well as at any time of symptomatic events (e.g., shock occurrence).
Sample
Criteria fo r  Sample Inclusion/Exclusion 
The target group consisted of ICD recipients who underwent follow-up 
examinations in the Medical Center Arrhythmic Clinic from January of 2000 to 
May of 2005.
The following inclusion criteria were utilized for this study:
1) Persons age 18 and above who had received an ICD and attended one or 
more ICD clinic visits at the medical center;
2) The documented occurrence of an appropriate shock (i.e., a shock delivered
in the presence of VT or VF), and/or an inappropriate shock (i.e., a shock 
delivered in the absence of VT or VF).
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2) An incomplete chart record regarding pertinent study data.
Data Collection 
Data Collection Instrument 
The data collection form was designed by the researcher and reviewed by 
two electrophysiologists for content validity (see Appendix D). Each item was 
designed to obtain appropriate demographic information and clinical characteristics. 
In addition, indications for ICD implantation, clinical history, underlying diseases, 
and prescribed medications were recorded. Device information and the history of 
shock events were integrated as well.
Validity and Reliability o f the ICD Records and Charts
Records from medical charts and ICD records offer objective evidence (Eder, 
Fullerton, Benroth, & Lindsy, 2005). Descriptions o f events reported by patients 
and their families were recorded by an examining physician shortly after the actual 
1ST events. Therefore, error variance in research conclusions should be minimized 
by the short time interval between the occurrence o f the event and its report.
To minimize the variability and increase the precision o f measurements, all 
data were collected by the researcher and confirmed by an electrophysiologist. Thus, 
concerns of inter-rater reliability have been minimized.
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concerns of inter-rater reliability have been minimized.
Data Collection Procedures 
Following appropriate IRB approval from the major university medical center 
in Southern California that served as the data collection site, the researcher 
collected data from the clinical charts of ICD recipients who had attended ICD 
clinics from January 1, 2000 to May 31, 2005. The researcher examined the charts 
to confirm that the criteria for study inclusion were met. Once the established 
criteria were met, the researcher recorded the data of applicable subjects on the 
collection sheet (Appendix E).
Data Analysis
This study utilized descriptive statistics, correlations, and regression models 
to perform the required statistical analyses. Calculations were performed by using 
SPSS 13 for W indows (SPSS, Inc., 2005).
For the purposes of this study, appropriate shock was defined as a shock 
developing in the presence of VT or VF, and inappropriate shock therapy (1ST) was 
defined as a shock developing in the absence o f VT or VF. For data analysis 
purposes, the occurrence of inappropriate shock therapy was considered as the 
dependent variable. Independent variables included sex, age, NYHA Functional 
Class, LVEF, structural / nonstructural heart disease, and AF/atrial tachycardia.
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two groups: ages < 65, and ages ^ 65. The convention within medical literature is 
to present LVEF by range. Thus, the researcher utilized the three levels of 
classification of LVEF ranges utilized in the literature: normal ^  50%, moderately 
depressed: 35-49%, severely depressed ^ 34 %. Therefore, in this analysis, ordinal 
variables (e.g., NYHA functional class, LVEF) and age group were used in chi- 
square procedures to test the frequencies of categorical variables related to 1ST.
The following statistical analyses were performed to achieve the specific 
aims o f this study. Continuous data, such as age and follow-up months, were 
expressed as a mean and standard deviation (M ± SD). Categorical data were 
compared utilizing a chi-square test. Predictors o f risk factors were determined by 
multivariate logistic regression analysis. The alpha level for this study was 
established at 5% (p = .05). Correspondingly, when the probability o f making an 
alpha error was equal to or less than 5% (p < 0.05), the result was considered as 
statistically significant.
To achieve Specific Aim #1 (to describe the incidence o f appropriate and 
inappropriate shock occurring in a group of ICD recipients seen at the specified 
university medical facility between January 2000 and May 2005 for emergent and 
routine follow-up visits), variables were analyzed and the following descriptive 
statistics were performed.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1ST in patients with ICDs 52
Calculation of the following factors required special attention: the total 
number o f appropriate shock occurrence(s) and the total number of inappropriate 
shock occurrence(s); and the percentage o f appropriate shock and inappropriate 
shocks per total number of patients. These rates o f appropriate and inappropriate 
ICD shock therapies were determined by dividing the number of therapies 
experienced by the total number o f patients, by the number and percentage of men 
and women experiencing inappropriate shocks.
To achieve Specific Aim #2 (to describe the relative risk between 1ST and 
specific factors i.e., age, gender, heart disease severity, structural heart disease, non- 
structural heart disease, atrial fibrillation) the following steps were taken:
1) The frequency and proportion o f each clinical risk factor associated with an 1ST 
was first calculated.
2) The researcher then analyzed the relationships between each risk factor and the 
frequency of ISTs, using chi square testing. Following that, the researcher applied a 
logistic regression model to identify the clinical predictor(s).
Post hoc testing was employed to detect significant differences among the 
causes of an 1ST. If no significant differences were detected, the next step was to 
use another procedure to further investigate any relationships between the 
frequency of inappropriate shock therapy and certain variables and/or risk factors 
by adding a covariate in the event that another variable was confounding the results.
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To achieve Specific Aim #3 (to describe the frequency of ISTs in a group of 
ICD recipients by risk factors (e.g., atrial fibrillation, lead problems, double 
counting) and the frequency and proportion of each risk factor associated with an 
1ST, the following procedures were utilized. The number o f ISTs for each risk factor 
(i.e., the presence of atrial fibrillation, lead problems, double counting) was divided 
by the number of 1ST events experienced per patient, and by the total number of 
patients over time.
To achieve Specific Aim #4 (to investigate any significant correlations 
between relevant clinical factors and the occurrence of 1ST), an analysis examined 
the relative risks between structural heart disease, non-structural heart disease, heart 
disease severity and the incidence o f an 1ST. The clinical factors examined included 
antiarrhythmic medications taken, device mode, model, and device programming at 
the time of the inappropriate shock event.
Human Subjects
This study was a retrospective chart review with limited access to 
identifying personal information. Therefore, with the authorization o f an HIPPA 
Waiver (i.e., waiver of consent), in accordance with the HIPPA Privacy Rule, 45 
CFR 164, section 512 (I), the need for signed informed consent was waived. IRB 
approval was obtained from USD (Appendix E) and from UCSD Medical Center
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( Appendix F) prior to data collection. The direct risks to participants in the study 
were minimal and every effort was made to protect confidentiality. Only a code 
number was used to identify participants, and no patient identifiers appeared on any 
data collection sheet. All data were stored in a locked file cabinet at the 
researcher’s residence and only accessible to the researcher. All data were kept for a 
minimum of five years before being destroyed. Results were only reported through 
unidentifiable or aggregated means.
Risk Management
Only the researcher had access to the anonymous subj ect data throughout 
the research process. Prior to analysis, all subjects were assigned a case number.
The protected health information of each patient was not reused or disclosed for any 
purposes other than that of the study.
Potential Benefits 
There were no immediate, specific benefits to any individual subjects. 
However, the potential benefits o f this research to the society were significant. An 
enhanced understanding of the predisposing factors related to inappropriate shock 
can potentially assist health care professionals in providing more effective patient 
education and clinical interventions. In addition, such descriptive research can
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provide a basis for future research that ultimately may enhance the well being of all 
ICD patients.
Risk/Benefit Ratio 
Thus, from the discussion above, the potential benefits of this research 
outweighed the minimal risks to subjects in this study.
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CHAPTER IV 
RESULTS 
Subjects and Sample Characteristics 
Two hundred and twelve patients were listed on the Electrophysiology laboratory1 s 
ICD roster. Out o f that group, one minor patient (i.e., under 18 years old) was excluded. 
Also excluded were patients who came to the electrophysiology laboratory solely for ICD 
device implantations, generator changes, or lead replacement procedures. The researcher 
was unable to locate 22 charts and noted key data missing from the records of another 43 
patients. The remaining 119 patients had sufficient data for analysis and review. Figure 3 
illustrates the schematic summary o f subject inclusion.
Using the period from January 1, 2000 to May 31, 2005, data from 119 patient 
records were included in this study; a total of 2,868 months were analyzed. The mean 
follow-up period was 24.1 ± 16.2 months (ranging from 1 to 53 months). Patients with 53 
months of follow-up had received ICD implantations at an earlier time than in 2000.
Subject demographic and clinical characteristics are displayed in Table 3 The 
researcher’s chart reviews uncovered a variety o f indications for ICD implantation, with 
many patients having more than one type of heart pathology diagnosed. In examining the 
patients and their characteristics, the majority o f  participants were male (n = 98; 82.4 %); 
were NYHA Functional Class II (n = 39; 32.8 %); and had experienced a severe decrease 
in LEVF (n = 90; 75.6%). Only three subjects had nonstructural heart disease. With 
regard to age, there were slightly more patients in the elderly group (age > 65, n = 67; age
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n =  13
ICD Roster 
N = 2 \ 2
Included 
N =  119
Excluded 
n= 103
- ICD implantation generator 
changes, lead change from 
research site and referral from 
all other hospitals
-N o visit 
-Age <18
- Unable to find the location
- Data missing
Figure 3 Schematic Summary o f Subject Inclusion
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Table 3






Mean (in years)/Range 65.4 ± 15 (2 9 -8 9 )
<65 51.0 ± 9.6




















ARVD= Right Ventricular Dysplasia, HCM = Hypertrophy Cardiomyopathy 
DCM = Dilated Cardiomyopathy, ICM = Ischemic Cardiomyopathy,
SCD = Sudden Cardiac Death.
VT/VF= Ventricular Tachycardia/ Ventricular Fibrillation
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Data Analysis Related to the Aims o f  This Study
Specific Aim #1
Specific aim # 1 of the study was to describe the incidence o f appropriate and 
inappropriate shock occurrence in a group o f ICD recipients, as well as to account for the 
incidence of appropriate shocks and inappropriate shocks for patients who visited the 
medical facility between January 2000 and May 2005 for emergent and routine follow-up 
visits.
Descriptive statistical analysis was performed to determine the profiles of shock 
occurrence in this study group. In this follow-up period, with a mean time follow-up of 
24.1± 16.2 months (range of 1- 53 months), there were 90 subjects who had not 
experienced any shock treatment. Sixty shock events occurred for 29 (24.4%) patients; 16 
(13.4%) patients received 44 appropriate shocks and 13 (10.9%) patients received 16 
inappropriate shocks. Thirteen out o f 119 patients (11 %) experienced 1ST, and 12 out o f 
13 1ST subjects were men. Shock profiles are displayed below in Table 4
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Table 4 
Shock Profiles
Shock Type Number o f patients 
(% )N =  119
Number of Shocks
No Shock 90 (75.6) 0
Appropriate Shock(only) 16(13.4) 44
Inappropriate Shock (only) 9 (7.6) 16
Coexisting Shock 4 (3.4) -




Shock Total 29 (24.4) 60+
See Table 5 for other demographic information concerning the 1ST patients.
Table 5
Inappropriate Shock Therapy Patients Profile
Variables Outcome (Number o f Patients)
Gender Male (12) Female (1)
Age < 65 (6) > 6 5  (7)
NYHA Class 1(4) 11(2) 111(7)
LVEF >50% (2) 35- 49 %(1) <35% (9)
Structural HD Yes = 13 No = 0
Hx o f AF Yes = 10 No = 3
Specific Aim #2
The second specific aim o f this study was to describe four associations: the 
relative risk relationships between age group and 1ST; gender and 1ST, heart disease
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severity and 1ST; structural/ non-structural heart disease and 1ST; and the history of atrial 
fibrillation and 1ST.
To test the relationship between heart disease severity and 1ST, the researcher 
examined whether the incidence o f inappropriate shock correlated with ICD recipients’ 
severity of disease according to left ventricular ejection fraction (LVEF; i.e., very severe 
<35%, moderate severe 36-49%, normal > 50%). Additionally, the NYHA functional 
classes (i.e., I, II, III, IV) of structural heart disease were examined to identify any 
significant correlations with the ICD recipients’ non-stmctural heart disease.
Chi-square analysis was chosen to compare the 1ST group to the non-IST group in 
terms o f the frequencies of ordinal variables (i.e., NYHA functional class, LVEF) and 
categorical variables (i.e., structural heart disease and non structural heart disease) as 
related to an inappropriate shock. These findings are displayed in Table 6
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Table 6
Inappropriate Shock in Chi-Square Com6parisons between 1ST and Non-ISTpatients
(N = 119)




Sex Male (98) 12 86 1.242 .537
Female (21) 1 20
Age Group < 65 (52) 6 46 .809 .667
>65 (63) 7 59




LVEF > 50 % 2 8 1.792 .774
35-49 % 1 17
< 34 % 9 80
Structural HD Yes (115) 13 102 .410 .815
No (4) 0 4
Atrial Fibrillation Yes (13) 10 3 11.993 .002*
No (10) 3 70
df = 2, *p<.01
To characterize patients who were prone to develop an inappropriate shock, the 
researcher did the following: 1) comparison o f clinical variables; 2) analysis of 
characteristics, including demographic information; 3) examination o f subjects’ histories 
o f atrial arrhythmia, underlying heart disease, and ejection fraction; and 4) examination 
of the clinical characteristics o f each qualifying arrhythmia. None o f these variables was 
predictive of a future development o f 1ST, except atrial tachycardia arrhythmia. To
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account for the difference in the relationship between these potential risk factors,
regression models were used; however, no predictive variables were identified. Details of




Model Fitting Likelihood Ratio Tests
Criteria____________________________________________________
-2 Log
Effect Likeliness of 
Reduced Model
Chi-Square df P
Intercept 37.080 .000 0
Age Group 38.487 1.407 2 .495
Gender 38.489 1.409 2 .494
NYHA Class 47.543 10.463 6 .106
LVEF 38.146 1.066 4 .900
Structural 37.187 .107 2 .948
AF /Atachy 51.959 14.879 2 .001*
*p = .001.
As depicted in Table 6, atrial fibrillation was significantly correlated with the 
incidence of 1ST iX ~  11.993, p = .002). However, gender (%2 = 1.242, p = 5.37), age (%2 
= .809, p = .667), NYHA (x = 8.731, p = . 189), LVEF (x2 =1.792, p =.774), and structural
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heart disease (%2 = .410, p = .815) were not statistically significant identifiers for 1ST.
These same variables were repeated using a logistic regression analysis, and 
results were similar. In this analysis, atrial tachyarrhythmia demonstrated an even higher 
significance in the regression analysis (x = 14.879, p = .001) than in the chi square 
analysis (p = .002).
Specific Aim #3
This study’s third specific aim was to describe the frequency o f ISTs in a group of 
ICD recipients by risk factors (e.g., atrial fibrillation, lead problems, double counting). 
Thus, descriptive statistics evaluating the frequency and proportion of each risk factor 
associated with an 1ST were performed.
The number of ISTs for each independent variable (e.g., atrial fibrillation, double 
counting) is reported and divided by the number o f inappropriate shock therapies 
experienced per patient and by the total number o f patients over time.
IST’s occurred in eight patients in the presence o f atria arrhythmias (i.e., flutter, 
fibrillation) or sinus tachycardia. In one subject, an 1ST occurred following a missed 
dose of mexiletine. Other concurrent clinical events included double counting and T-wave 
over-sensing secondary to an imbalance of electrolytes. Table 8 displays the incidence of
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1ST by variable factors.
Table 8














8 2 2 1 1 13
Number of 
1ST
10 2 2 1 1 16
NSR= normal sinus rhythm, ST = sinus tachycardia 
Specific Aim #4
The study’s fourth specific aim was to investigate significant correlations between 
clinical information and an 1ST, and, taken in combination, to reveal any clinical 
predictability for the incidence o f an 1ST. Variables analyzed include demographic 
characteristics, histories of previous underlying heart disease, ejection fraction, and 
medications taken at the time o f the 1ST.
Medical charts and ICD follow-up records were reviewed for the clinical 
characteristics o f the presenting arrhythmia. All information regarding episodes of stored 
arrhythmias were recorded at the discretion o f the physician treating the individual 
patient. The elements recorded in the subject record as possible predisposing factors 
triggering ISTs are discussed below.
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Most patients at risk for an 1ST had severe chronic heart disease and multiple 
independent risk factors for atrial fibrillation. More than 70% of the ICD patients had 
significant coronary artery disease, and most had severe left ventricular dysfunction with 
an ejection fraction of less than 30%. A minority o f ICD patients (n = 3) had normal 
coronary arteries and electrically compromised, right ventricular dysplasia, mitral valve 
prolapse, or hypertrophic cardiomyopathy (HCM). Most ICD patients were also at risk 
for potential triggers of inappropriate shock known to precipitate atrial fibrillation and 
lead to SCD if left unchecked. These triggers included hyperthyroidism, diabetes mellitus, 
and valvular heart disease.





























Cause o f 1ST 
Event
Mode AA Drug 






1 82 VT CHF Chr AF CABG II 35 VVIR Metoprolol 49 Up grade to
M Syncope One shock due to AF Lanoxin dual chamber
Hypothyroidism Charge time 6.55 sec. ICD
2 68 VT ICM NSVT I 58 Missing one dose of DDD Coreg Digoxin 25 M onitor VT
M PAF Mexiletine Amidarone
3 48 DCM NIDCM III 10 Lead dislodge Biv Coreg Laoxin 18 Reposition
M HTN ESRD DDD lead
4 85 VT MVP I N/A Discharge for AF VVI Coreg Digoxin 53
M



































Cause of 1ST Shock 
Event






6 44 DCM CHF III 24 Sinus tachycardia as VT Biv Coreg Digoxin 7 VT zone




7 48 HCM A FRV R II 34 One shock for AF DDDR 46
M
8 71 CHF I 18 One shock DDDR Mexiletine 22 Arrange DFT
M DCM AF for atrial flutter Sotalol Lanoxin testing
9 74 VT ICM I 35 Shock for SVT and AF DDDR Sotalol 41 Coreg increase
M RVR Laoxin to 625 mg. DFT
Dehydration, Creatine f Amidarone remained stable





















Pt Ag Implant History N E Cause of 1ST Shock Mode A A Drug at time F- Intervention




10 49 VT TOF VHD III 30 One shock for A Tachy DDDR Coreg 10 Since ICD firing
M secondary induced by 
exercise
in VT zone 
during exercise 
induced ST. 
After VT turned 
off. VT 
Ablation
11 79 AVRD NSVT SMVT I 72 Two shocks for sinus Biv Cozaar 53 No evidence for








12 54 ICM Chr. AF II 30 One shock due to double Biv Coreg 18 Rate increase to
M NIDCM counting DDD Digoxin 175, VT interval 
decrease to 343 
ms
13 48 NICM C hrA F III 22 4 shocks - 3 for VT VF Biv Coreg , Cozaar 22 ICD normal
M 1 for AF RVR while 
performing stress test
DDD Digoxin function 
Recommend 
rate control
AF = atrial fibrillation
PAF = paroxysmal Atrial fibrillation 
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Description o f  131ST Patients
As presented in Table 9, in the 1ST group, all patients had structural heart disease.
Twelve patients were men. Subjects aged 65 years and older were slightly more 
numerous than younger patients (7 vs. 6), but this difference was not statistically 
significant. Eleven out o f 13 patients had LVEFs that were severely depressed (i.e., below 
35%), but there were no patients experiencing 1ST that had moderately depressed LVEFs. 
Two patients had a normal LVEF: 1) a patient with an LVEF o f 58% who had CAD 
NSVT; 2) another patient with an LVEF of 72% who had poor right ventricular function 
due to right ventricular dysplasia.
The major causative factor of 1ST in this group was atrial fibrillation (n = 8). Two 
patients had sinus tachycardia. Double counting occurred in two patients, one patient’s 
1ST was associated with lead dislodgement, and another patient’s 1ST was caused by 
missing one dose o f Mexiletine. This type o f event has been posited to be associated 
with an increased defibrillation threshold (DFT) (Murakawa, Yamshita, Kanese, Omota, 
1998; Rajawat, Patel, Gerstenfeld, Nayak, and Marchinski, 2004).
Regardless o f a variety o f indications and disease diagnoses (including two 
patients with congenital heart disease), 10 out o f 13 subjects who experienced 1ST had 
coexisting chronic AF or paroxysmal atrial fibrillation (PAF). Finally, three patients had 
no history o f chronic AF; however, they all had at least one inherited risk factor for 
developing AF.
Another finding from this group was the importance o f occurrences o f trigger 
events. In two patients (Patient 1 and Patient 4) the ICD device was suspected to lack the 
ability to discriminate between SVT and VT, and, after changing W I  mode to DDD,
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there was no further 1ST. However, 1ST occurred in the remaining patients who were 
implanted with a dual chamber device (Patient 5) and a biventricular device (Patient 6 
and Patient 8). According to chart records, a missed Mexiletine dose was suspected to be 
the trigger of the 1ST secondary to alternating defibrillation threshold for Patient 2.
Two subjects receiving ISTs had similar situations. Patient 10, who had atrial 
tachycardia, received an 1ST while he was performing extreme exercise, and Patient 13 
received an 1ST while he was undergoing a stress test. The patient activity at the time of 
the lead dislodgement case (Patient 3) was not recorded. However, all of these three 
patients were males and in their 40s.
Summary
The major finding o f this study was a significant correlation between the occurrence o f 
atrial fibrillation and the incidence o f 1ST. The trigger events precipitating 1ST were 
varied in this study population, and their salience as clinical predictors o f 1ST are 
discussed in the next chapter.
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Figure 3
Patient 10 received an 1ST while he was performing extreme exercise.
An inappropriate shock from atrial fibrillation with rapid ventricular response.
1 | »  M/a
Figure 4
Patient 13 received an 1ST while he was undergoing a stress test.
Inappropriate shock from a sinus tachycardia that had a ventricular rate fast enough to be 
detected in the VT zone o f the device
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This investigation is an updated cohort study o f inappropriate shock therapy. The 
study represents the first research findings from a nursing perspective on the 
physiological aspects of 1ST in ICD recipients. Unlike previous cohort studies that only 
present the rates o f causes o f 1ST, including the most recent such study by Thenus et al. 
(2005), this study explores underlying trigger events by incorporating these events at the 
time when 1ST occurred, as well as by correlating subjects’ clinical histories.
The actual data collection period of Thenus et al.’s (2005) study is not indicated; 
but the observation period o f this present study was specifically conducted at a teaching 
hospital as well as a tertiary referral hospital in Southern California from July 2000 to 
May 2005, with a mean follow-up period of 24.1 ± 16.2 months.
Overall, this study reveals that, in 13 (9%) out of 119 patients who received 
inappropriate shock, AF remained the major cause o f 1ST. In addition, 12 out o f 13 
patients receiving ISTs were men. The researcher posits that ISTs may be related to m en’s 
increased risk for atrial fibrillation. However, given that 98 out 119 patients (82.4%) 
were men, this conclusion is based on a small sample size that failed to achieve statistical 
significance and must be viewed with caution (%2 = 0.995, p > .05).
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Incidence Rates
In previous cohort studies, incidence rates of 22% (Grimm et al., 1993) and 14% 
(Rinaddi et al., 2004: Thenus et al., 2005) were documented, and inappropriate ICD 
therapy was attributed to atrial tachyarrhythmias. However, it is unknown what 
percentage of total events atrial tachyarrhythmias constituted in Thenus et al.’s study.
The incidence o f ISTs in this present study was 11%. This lower incidence might be due 
to the following reasons: (a) continuous refinement in the ICD devices; (b) rigorous 
procedures for performing a follow-up visit. The incidence rate also may have been 
underestimated because of patients lost to follow-up (e.g., moving, traveling, inability to 
locate patient or chart). However, those events also occur in most retrospective cohort 
studies.
Age and Gender
As in previous studies (Grimm et al.1993; Nanthakumar, 2003; Rinaddi, 2004; 
Thenus et al., 2005), the present study did not show any significant difference in age and 
gender between the 1ST group and the non-IST group. Even though 12 out of the 13 1ST 
subjects were men, the large proportion o f men receiving this form o f treatment was not 
significantly different between the groups (p = .537).
Atrial Fibrillation
Previous studies have investigated whether clinical variables could predict the 
delivery of 1ST in ICD recipients. Rinaddi et al. (2004) and Nanthakumar et al. (2003) 
observed previous histories o f AF at the time o f implantation to predict the incidence o f 
inappropriate shock for patients with single chamber ICDs. Since the first cohort study 
(Grimm et al., 1993), and despite the advent o f DDD, AF still remains the major cause o f
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1ST in Patients with ICDs 75
1ST (Thenus et al., 2005).
NYHA Functional Class 
Nanthakumar et al. (2003) also noted that NYHA Class I could predict 1ST. In 
this study, however, the subjects’ statuses o f function classes fluctuated and could not 
reflect the level o f severity for heart disease. Therefore, it was not surprising that 
identification o f significance was not achieved at the level o f NYHA Functional Class.
Ejection Fraction
As in the work of Thenus et al. (2005) and the present study did not found any 
significant differences in this factor related to the development of 1ST. One explanation 
could be that, although the value of LVEF is more objective (e.g., measured by rest 
technetium-99m-methoxy-isobutyl-isonitril (MIBI), echocardiography, or by the 
guideline o f indications in Gate Bayesian Reconstruction In Emission Tomography 
[SPECT]), most patients were amalgamated into the severely depressed LVEF category 
in order to receive ICD therapy.
Eleven out of 13 patients with at least one 1ST experience had severely depressed 
LVEFs. However, other subjects with severely depressed LVEF had experienced no 1ST 
event. Therefore, the data could not support this variable as a clinical predictor.
Structural Heart Disease 
A previous study (Rinaddi et al., 2004) posited that, while DCM patients 
comprised 50% of the study participants, a higher incidence o f 1ST (80%) occurred in 
these patients. Rinaddi et al. concluded that patients with DCM were more likely to be at 
increased risk for ISTs. In this study with expanded indications, a variety of diagnoses are 
shown to have been occurring in ICD recipients. Because most patients had multiple
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forms o f heart diseases as well as other disease processes, DCM could not be considered 
as an independent variable, or as a clinical predictor. However, after grouping heart 
disease into structural and non-structural categories, the results demonstrated that almost 
all ICD recipients had structural heart disease (n = 116). Therefore, the number of 
patients with non-structural heart disease (n = 3) was too small to utilize structural heart 
disease as a grouping variable to test for statistical significance.
Lead Problems
Lead problems are the second major cause o f ISTs, as reported in many articles 
(Dorwarth, et al, 2003; Goyal, et al, 2004; Picket et al, 2004). In the present study, only 
one patient had an 1ST related to lead dislodgement. While another patient did have a 
lead fracture; however the lead was replaced in a timely fashion by rigorous integration, 
which contributed to be the lowered occurrence rate 1ST, as the researcher noted in the 
ICD record.
Double Counting
In this study, 1ST caused by double counting occurred in two cases in an early 
observation with the first generation o f BiV ICD. Although dedicated BiV ICDs are now 
available with tachycardia detection only occurring through a single (RV) channel, 
continued follow-up of the many patients who received first-generation devices is needed.
Drug Interaction
In the present study, a unique finding not found in previous cohort studies was 
that an 1ST can be caused by missing one dose o f  Mexitil (i.e., mexiletine). In this patient, 
population, mexiletine function in a fashion similar to lidocaine to reduce the 
development o f ventricular tachycardia, as has been used in hybrid therapy o f ICD
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recipients (Rajawat, Patel, Gerstenfeld, Nayak, & Marchinski, 2004). However, animal 
studies had reported that treatment with mexiletine increases the defibrillation threshold. 
Thus, suddenly missing one dose led to altering the serum level o f mexiletine, which then 
lead to an 1ST (Bride et al, 1997). As a result, the association of missing one does of 
Mexitil and 1ST, is suspected.
Electrolyte Imbalance 
Another 1ST event occurred when a patient was hospitalization for VT/VF. 
Predisposed dehydration increased the serum level o f creatine and potassium, as the 
interrogation revealed VT and AF with rapid ventricular response.
Events Occurring at the Time o f Inappropriate Shock Therapy Episodes 
In this study, eight patients’ 1ST were found to be AF/atrial tachycardia or SVT. In 
one case, there was no recorded trigger event; and in another case, the patient’s single 
chamber ICD was replaced by a dual chamber ICD to solve the problem. Another patient 
was asked to increase the dosage o f antiarrhythmics. Yet another patient was asked to 
take anti-thyroid. Adjustment o f the defibrillation threshold and ablation were performed 
for two different patients to solve the 1ST problem. For the remaining two patients in the 
1ST group, one 1ST occurred at the time when the patient was undergoing a testing 
procedure, the other 1ST occurred at the time when the patient was performing extreme 
exercise. Therefore, the clinical characteristics o f patients prone to 1ST should be 
incorporated into intervention plans.
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Clinical Implications 
Because ICDs are a lifesaving device, the unexpected failure o f one can be 
catastrophic. Thus, the findings from this study may have clinical implications that relate 
to the safety of ICD recipients. The following are this researcher’s suggestions:
1. Early identification of the etiology o f unnecessary shocks to allow for the 
immediate institution o f therapy to reduce the risk for subsequent events;
2. Careful monitoring of concomitant anti-arrhythmic drug (AAD) therapy in 
patients with ICD;
3. Reinforcement o f the need for careful electrode lead and generator placement to 
reduce 1ST events;
4. Increased awareness that certain testing procedures (e.g., stress tests) may 
predispose the patient to 1ST;
5. Development of an updated and effective education program for nurses caring for 
ICD patients that incorporates current research findings regarding assessment for 
risk factors for 1ST and patient/family education regarding these factors.
Ultimately, the goal is to ensure that ICD recipients achieve optimal care and
recovery status.
Limitations
This study has several limitations. One major limitation is that it is based on a 
retrospective design. Data were collected through chart reviews and ICD records. Some 
of the information that the researcher needed was difficult to obtain. For example, if  a 
patient expired at another hospital, the cause o f death was unknown and the researcher 
could not know if  any relationship existed between the cause o f death and ICD device.
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Other patient records may have been lost or were taken elsewhere (e.g., a patient might 
move out o f the area). In addition, without the ability to contact patients, the researcher 
was unable to know where missing charts were located or about the existence o f charts in 
other facilities.
This preset study data did not address the role o f the programming in the genesis 
of 1ST as different programming modalities can influence the effectiveness o f shock 
therapy. In addition, the researcher was not able to record all medications taken by the 
ICD recipients, and medications can alter ICD therapy. Further, the researcher was unable 
to obtain all ICD records for review, especially in the event of an 1ST occurring outside o f 
the study site. For these reasons, the researcher may not be in a position to clearly assess 
the effects o f risk factors and can only note inappropriate therapy prevalence based on the 
ICD records.
The major limitation of this study is its related small number o f  subjects limited 
to a single-center ICD clinic registry. As such, the conclusions could be buttressed by 
using larger multi-center registries or prospective data from future ICD research. 
Especially important would be focusing on data issues and avoid any potential bias 
resulting from incomplete data. At the outset, this researcher considered 1ST as the most 
clinically relevant event. Inappropriate anti-tachycardia therapy (ATP) that resulted in no 
shock or appropriate shock therapy was not assessed. Reasons for not including ATP were 
primarily due to missing data secondary to the ICD’s memory limitations, incomplete 
interrogation, or cleared memory. Inclusion o f any o f these data could provide a fuller 
understanding o f 1ST phenomenon.
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Suggestion for Future Research 
Despite the technological evolution o f ICD devices, AF/atrial 
tachycardarrhythmia remains the major cause of 1ST. Efforts in future research should 
include investigations into the events arising from AF/atrial tachycardarrhythmia and 
clinical histories that could predispose patients to AF/atrial tachycardarrhythmia. Thus, 
the responses o f ICD patients to triggered heart-rate exercise should be carefully studied. 
Since antiarhythmics have become an integral part of hybrid therapy, the alteration o f the 
defibrillation threshold by these medications also should be a focus o f future research. As 
an 1ST can be triggered by an electrolyte imbalance, there is a need to investigate the 
pathways by which an imbalance in specific electrolytes (e.g., potassium) are promoting 
the occurrence o f 1ST. Because o f the serious consequences o f  device malfunction (e.g., 
sudden death), providing a patient alert system, surveying the reasons for patients missing 
a follow-up appointment, and developing a the strategy to assist ICD recipients to 
continue regular follow -  up should be encouraged. The early detection o f device 
malfunction and immediate replacement could avert a tragedy from occurring.
In addition, little is known regarding undersensing as a contributing factor to 1ST , 
and future research should focus on this area. Although inappropriate antitachycardia 
pacing may not be as serious as an 1ST, the wrong detection information can significantly 
alter hemodynamic functioning. Future research studies that explore more fully all 
inappropriate discharges may be made possible as increased memory electrogram storage 
in the ICD expands.
Despite expanded indications for the use o f the ICD, the percentage o f women 
receiving ICD therapy has not increased. This continuing persistent gender differential in
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ICD therapy may need to be investigated using qualitative and quantitative methods, as a 
complex set o f  physiological and contextual factors may be operant.
This study represents an initial step in the growing body o f knowledge regarding 
an expanding patient population. In the future, a multisite expanded longitudinal study 
will be necessary to confirm the results seen in this study and more clearly elucidate the 
multi-factorial nature o f inappropriate shock therapy.
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Trails o f  IC D  Therapy f o r  the Secondary P revention o f  SCD
Table 1
Trails o f  ICD Therapy fo r  the Secondary Prevention o f SCD
Study /Study Period Population Characteristics, 
N= total







-SMVT with near syncope, 
-SMVT with EF < 40% & 
symptoms.
•ICD therapy vs Antiarrhythmic 
(Amiodarone, Sotalol) therapy
•Total mortality 
•Mode of death 
•Quality of life 
•Cost benefit
•The ICD group experienced a 39% 
reduction death in the first year with a 
27% and 31% reduction in years two 
and three.
• Enrollment was discontinued 
prematurely because of a significant 





•Resuscitated after out-of hospital 
cardiac arrest 
-documented VF 
-SMVT with syncope 
-SMVT with EF<35%
•ICD (n=328) vs 
amiodarone (n=331)
•Primary end point: 
All causes mortality 
•Secondary end point: 
arrhythmia death
A relative reduction occurred in all 
cause mortality of 19.7% in ICD group. 
A 33% reduction occurred in 
amiodarone group(this reduction did not 
reach statistical significance).
•Result supports ICD is better than 
Amiodarone in the treatment of patients 
with MSVT or resuscitated cardiac 
arrest.
CA SH /1987-1998
Cadiac Arrest Study 
Hamburg
•N = 288
• Resuscitated after cardiac arrest 
secondary to documented 
ventricular arrhythmia 
•ICD (n=99) vs
amiodarone (n=92), metoprolol 





Recurrences of cardiac 
arrest requiring CPR 
*Recurrences of unstable • 
Angina
Preliminary results showed that 
propafenone treatment is less effective 
than ICD treatment. Therefore, this arm 
was suspended. The ICD group 
experienced a 24% relative reduction in 




















Summary> o f  ICD Trails fo r  the Primary Prevention o f SCD










• N= 900, age < 80
• EF <36% & 
•Abnormalities on -  
average signal ECG
- Randomly assigned in 
OR after CABG







•The trail was prematurely terminated because 
mortality was equal in the CABG plus ICD(101 
deaths) compare CABG alone 95 deaths; 
demonstrated no benefit of the prophylactic 
insertion of an ICD in patients with an ischemic 
burden and a depression EF undergoing 
appropriated coronary revascularization.











-NVST, VT 3 to30 
beats; -Inducible and 
non suppressible VT/ 
VF on EPS, not 
suppressed by IV 
procainamide)
•101 drug therapy (80 
on Amiodarone)










•39 (39% ) deaths in antiarrhythmic group vs 
15 (21%) ICD group
Hazard ratio, 0.46; Cl, 026-0.82; p = 0.009) 




















Trail / Study Period Study Population 
N= Total








•More than lw eek post 
MI,
-NYHA class I, II, III
- EF<0.40
- Inducible VT on EPS.
-  NSVT >3 beats,
EP guided 
antiarrhythmic 






or death from 
arrhythmia
•Significant reduction in rate of cardiac 
arrest or death from arrhythmia with EP 
guided therapy; nearly all benefit 
attributable to ICD implantation







• Inclusion criteria : 
-With MI > 1 month 
-EF<35%,
-NYHA class I, II, or 
III
•Exclusion criteria : 
-CABG or non CABG 
revascularization< 
3months prior to 
enrollment 
•ICD (n=742),








Conventional Medical therapy (n= 97,19.8
%)
ICD group (n= 105, 14.2%)
•Hazard ratio 0.69 (95% Cl, 0.51-0.93). 



































>10 PVCs/hr or NSVT 
•Optimal medical 
therapy, n =229.













end p o in t: 
All kinds of 
death
• Death from any cause; in 
-ICD group(n=28),
-Conventional medical therapy (n= 40) 
•Sudden death from arrhythmia in 
-ICD group (n=3),
-Conventional medical therapy (n= 14) 
*Significant reduction in overall mortality 
in ICD group.









Heart failure patients 
(NYHA class III-IV) 
with EF < 35%, QRS > 









2. OPT + CRT-P






n * as 
measured by 
time to first 
event
• A pacemaker with CRT capabilities (CRT- 
P), in combination with OPT, reduced the 
risk of all-cause mortality or first 
hospitalization* by 19% when compared 
with OPT alone.
• A defibrillator with CRT capabilities 
(CRT-D), in combination with OPT, 
reduced the risk of all-cause mortality or 
first hospitalization* by 20% when 
compared with OPT alone.
• CRT-D, in combination with OPT, 
reduced the risk of all-cause mortality by 






















Study Groups Endpoint(s) Key Finding(s)






NYHA II-III, CHF, 
EF<35%




















•Amiodarone has no favorable effect on 
survival, single lead.
•Shock only ICD therapy reduces overall 
mortality by 23 %.
Conclusions: NIDCM treated with ACE 
inhibitors and beta-blockers, the 
implantation of a cardioverter-defibrillator 
significantly reduced the risk of SCD from 
arrhythmia and was associated with no 
significant reduction in the risk of death 
from any cause.
Abbreviations:
CAD = coronary artery disease; CHF= congestive heart failure;
EPS = electrocardiphysiology Study; ICD = Implantable Cardioverter- Defibrillator;
EF (LVEF) = left ventricular ejection fraction; NYHA = New York Heart Association Functional Class; 
NIDCM  = nonischemic dilated cardiomyopathy;
NSVT = non sustained ventricular tachycardia; PVC= premature ventricular contraction;
SM VT= sustained monomorphagic ventricular tachycardia; VT= ventricular tachycardia.
CRT- P = cardiac resynchronization therapy -  pacemaker 
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Appendix B
2002 Indications fo r  Implantable Cardioverter - Defibrillator Therapy
 _____________________ (ACC/AHA/NASPE) Practice Guidelines______________________
Class I: Conditions for which there is evidence and/or general agreement that a given 
procedure or treatment is beneficial, useful, and effective.
Class II: Conditions for which there is conflicting evidence and/or a divergence of 
opinion about the usefulness/efficacy o f a procedure or treatment.
Class Ha: Weight o f evidence/opinion is in favor o f usefulness/efficacy.
Class lib: Usefulness/efficacy is less well established by evidence/opinion.
Class III: Conditions for which there is evidence and/or general agreement that a 
procedure/treatment is not useful / effective and in some cases may be harmful.
Class I indications per level of A, B or C
A. Data were derived from multiple randomized clinical trails involving a large 
number o f subjects.
B. Data were derived from a limited number o f trails involving comparatively small 
of patients from well designed data analysis data analysis o f nonrandomized 
studies or observational data registries.
C. Consensus o f expert opinions was the primary source or recommendation.
Class III indications are patients in whom ICD therapy is no appropriate.
CAD, coronary artery disease; EP. electrophysiology
Class I
1. Cardiac arrest due to VF or VT not due to a transient or reversible cause. (Level A)
2. Spontaneous sustained VT in association with structural heart disease. (Level B)
3. Syncope o f undetermined origin with clinically relevant, hemodynamically significant
sustained VT or VF induced at electrophysiologic study when drug therapy is 
ineffective, not tolerated, or not preferred. (Level B)
4. Nonsustained VT in patients with coronary disease, prior MI, LV dysfunction, and
inducible VF or sustained VT at electrophysiologic study that is not suppressible by a 
Class I antiarrhythmic drug. (Level A)
5. Spontaneous sustained VT in patients without structural heart disease not amenable to
other treatments. (Level C)
Class Ha
Patients with left ventricular ejection fraction o f less than or equal to 30% at least 1 
month post myocardial infarction and 3 months post coronary artery revascularization 
surgery. (Level B)
Class lib
1. Cardiac arrest presumed to be due to VF when electrophysiologic
testing is precluded by other medical conditions. (Level C)
2. Severe symptoms (e.g., syncope) attributable to ventricular tachyarrhythmias in
patients awaiting cardiac transplantation. (Level C)
3. Familial or inherited conditions with a high risk for life-threatening ventricular
tachyarrhythmias such as long-QT syndrome or hypertrophic cardiomyopathy. (Level
B)______________________________________________________________________________
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4. Nonsustained VT with coronary artery disease, prior MI, LV dysfunction, and
inducible sustained VT or VF at electrophysiologic study. (Level B)
5. Recurrent syncope of undetermined origin in the presence o f ventricular dysfunction
and inducible ventricular arrhythmias at electrophysiologic study when other causes 
o f syncope have been excluded. (Level C)
6. Syncope o f unexplained origin or family history of unexplained sudden cardiac death
in association with typical or atypical right bundle-branch block and ST segment 
elevations (Brugada syndrome). (Level C)
Class III
1. Syncope o f undetermined cause in a patient without inducible ventricular
tachyarrhythmias and without structural heart disease. (Level C)
2. Incessant VT or VF. (Level C)
3. VF or VT resulting from arrhythmias amenable to surgical or catheter ablation; for
example, atrial arrhythmias associated with the Wolff-Parkinson- White syndrome, 
right ventricular outflow tract VT, idiopathic left ventricular tachycardia, or fascicular 
VT. (Level C)
4. Ventricular tachyarrhythmias due to a transient or reversible disorder (e.g., AMI,
electrolyte imbalance, drugs, or trauma) when correction o f the disorder is considered 
feasible and likely to substantially reduce the risk o f recurrent arrhythmia. (Level B)
5. Significant psychiatric illnesses that may be aggravated by device implantation or may
preclude systematic follow-up. (Level C)
6. Terminal illnesses with projected life expectancy less than 6 months. (Level C)
7. Patients with coronary artery disease with LV dysfunction and prolonged QRS duration
in the absence o f spontaneous or inducible sustained or nonsustained VT who are 
undergoing coronary bypass surgery. (Level B)
8. NYHA Class IV drug-refractory congestive heart failure in patients who are not
candidates for cardiac transplantation. (Level C)__________________________________
From “ACC/AHA/NASPE 2002 guideline update for implantation o f  cardiac pacemakers and 
antiarrhythmia devices: Summary article,” by G., J. Gregoratos, J. Abrams, A .E. Epstein,, 2002, 
C i r c u l a t i o n ,  1 0 6 ,  pp. 2145-2161.












Nursing Research Related to Care of ICD Recipients 
(Studies are presented in Chronological Order)
Author/Year Purpose Study Design Subjects 
N= total





Patients with ICDs and 
their conceptions of their 
life situations
A 12-month descriptive 
longitudinal study was 
carried out during a 




Overall uncertainty showed a 
decrease over time. A statistically 
significant difference was found 
within the domain “uncertainty” 
related to information, suggesting 
the need for more education in 





To evaluate the effects of 
biofeedback training used 




used in cardiovascular 
health education 





Psychosocial therapy significantly 
reduced risk of cardiovascular 




To describe changes in 
the life situation of 
patients with an ICD over 






Regarding their overall life 
situations, patients expressed 
increased satisfaction as well as 
less uncertainty and fear. The 
research indicates that patients 
need more information about 
typical changes in patients’ life 




















Purpose Study Design Subjects 
N= Total





To describe how well the 
ICD recipients cope with 
their situations when they 
have the support of a 
nurse, and
contrast this data with 
that from a control group 
receiving conventional 












education by a 
physician (n = 10).
Sleep disturbances were the 
greatest problem in both the 
study group and the control 
group before ICD implantation. 
The control group showed need 
for more information regarding 
the function o f  the ICD device. 
By means of a questionnaire, 
interviews and observations, the 
study revealed great need for 
information, and therefore that 
planning ways to create this 




To explore the nature of 
patients’ partners’ 
experiences from the pre- 
ICD implantation phase 
up until a maximum of 
20 months at home.
Qualitative study
based on a semi-structured
schedule
Eight partners 
cohabiting with a 
recipient of an ICD
Four themes representing 11 
categories conceptualized the 
partners' experiences, including: 
Acknowledging the patient's 
need for the device, reactions to 
the device, Feeling grateful, 
Waiting for the shock, Knowing 
what to do to safeguard the 



















Author/ Year Purpose Study Design Subjects
N=Total





1) To describe the 
domains of concerns of 
intimate partners of 
sudden cardiac death 
(SCD) during the first 
year after ICD 
implantation;
2) To outline the strategies 
used by partners of SCD 
survivors in dealing with 
the concerns and demands 
of recovery during the 
first year after ICD 
implantation.
Secondary analysis of 
interview data collected 










Eight domains of concerns :
I) Care to ensure survival; 2) 
The p a rtner’s self-care; 3) The 
relationship; 4) The ICD;
5) M oney matters; 6) The 
future; 7) Health care providers 
and family,
or, education & support sources; 
1) Information on the function 
of the ICD; 2) Normal 
progression of physical and 
emotional recovery experiences; 
3) Safety and maintenance of 
the ICD; 4) Activities of daily 
living with the ICD; 5)





To evaluate the effects of 
a short-term intervention 
for the initial ICD 
recipients
Experimental.
A structured telephone 
intervention delivered 
during the first 8 weeks 
after ICD therapy by 
expert cardiovascular 
nurses
N =  168
Individuals who had 
experienced a first 





Decreased ICD related physical 
symptoms and anxiety, and 


























To explore how ICD 
recipients perceive their 




N = 21 ICD 
recipients
Physiological deterioration, 
cognitive changes, perceived 
social support, dependency, 
feelings regarding the 
possibility o f  receiving a shock, 
and confrontation with 
mortality.
O ’ Brien 
et al 
/2004
Provide an update for 
clinicians on the effects 
of ICD storm* on 
patients and family 
members.
* Storm = a series of two 
or more ICD shocks 
(appropriately or 
inappropriately 
triggered) in succession 
within a 24 -  hour 
period.
Case report.
Literature review and 
interviews with patients 
who have experienced ICD 
storm
N = 6
Low number (4 or 
less) of ICD storm 
shocks(n=3)
High number (more 
than 4) of storm 
shocks(n=3)
1) Qualitative of life was 
negatively affected only in 
subjects who received more 
than 4 shocks.
2) Pain and fear are major 
concerns requiring 
psychological counseling.
3) There is a need for 
knowledge about the purpose 
of the ICD and self care 
methods effective in reducing 




To explore nurses' 
confidence and 
competence in preparing 
patients for having an 
ICD implanted and for 
life at home.
Survey.
A 28-point postal 
questionnaire to explore 
knowledge of the device 
and its impact.
N=152 nurses.
A purposive sample 
from cardiology 
departments in 4 
large teaching 
hospitals.
Knowledge of the ICD and its 
effects appeared poorly 
understood by all nurses, 
irrespective of additional 
qualifications, length of time 
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Appendix D
ICD INAPPROPRIATE SHOCK THERAPY STUDY DATA SHEET
Demographic and Clinical Characteristics 
Patient Information Subject Code
Age  Sex M  F__
Diagnosis / Indication
SCD V F/V T  MUSTT/MADITII  DCM  NIDCM  CHF_____
O ther____
History
Clinical History / Cardiac History before 
Underlying Disease
a. Heart disease - i) Other structural heart disease ii) Non structure heart disease
b. Heart disease severity
i) Left ventricular ejection fraction
ii) NYHA Functional Classes
c. Other significant disease
Device Information
Manufacturer : Guidant(G)  Medtronic(M)  St. Jude (S)___
Implantation date(s)
mode model Programmer
Shock Episode (s) History
Incidence of Shock Appropriate shock   Inappropriate shock ___
Description(s) of Inappropriate Shock(s)
1 .Energy of shock Joul
2.How was device programmed at the time o f shock
3.Drug(s) (Medications) at the time o f inappropriate shock
a. Anti Antiarrhythmic Therapy (AA medications) b. Amiodarone
4.Symptoms during at the time of inappropriate shock
5. Factors o f inappropriate shock
Termination of inappropriate shock
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APPENDIX F
Approval Letter From the Committee of Human Research - University of California San Diego
Medical Center
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
051123X
UNIVERSITY OF CALIFORNIA, SAN DIEGO 
HUMAN RESEARCH PROTECTIONS PROGRAM
TO: Dr. Ulrika Birgersdotter-G Mailcode: 8411
RE: Project #051123X
Incidence and Clinical Predictor o f Risk Factors for Inappropriate Shock in 
Patients With Implantable Cardioverter-Defibrillators (ICD)
Dear Dr. Birgersdotter-Green:
The above-referenced project was reviewed and approved on 9/1/2005 by one of this institution's 
Institutional Review Boards in accordance with the requirements of the Code o f Federal 
Regulations on the Protection of Human Subjects (45 CFR 46 and 21 CFR 50 and 56), including 
its relevant Subparts. The IRB determined that waiver of informed consent may be granted for 
this project as it meets the requirements outlined in 45 CFR 46.116(d). This 
approval, based on the degree o f risk, is for 365 days from the date o f IRB review and approval 
unless otherwise stated in this letter. The regulations require that continuing review be 
conducted on or before the 1-year anniversary date of the IRB approval, even though the 
research activity may not begin until some time after the IRB has given approval. In addition, a 
waiver of individual authorization for use of Protected Health Information (PHI) was granted by 
the Institutional Review Board as stipulated by the HIPAA Privacy Rule, 45 CFR 164 section 
512(1).
The Institutional Review Board determined that the proposed research satisfies following 
criteria:
1. The use or disclosure o f PHI involves no more than minimal risk.
2. Granting of waiver will not adversely affect privacy rights and welfare o f the individuals 
whose records will be used.
3. The project could not practicably be conducted without a waiver.
4. The project could not practicably be conducted without use of PHI.
5. The privacy risks are reasonable relative to the anticipated benefits o f research.
6. An adequate plan to protect identifiers from improper use and disclosure is included in 
the research proposal.
7. An adequate plan to destroy the identifiers at the earliest opportunity, or justification for 
retaining identifiers, is included in the research proposal.
8. The project plan includes written assurances that PHI will not be re-used or disclosed for 
other purposes.
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The PHI for which use has been determined to be necessary by the IRB includes:
1. Medical records of Implantable Cardioverter-Defibrillators (ICD) recipients who
underwent follow-up examination at 3 month intervals from January 1, 2000 to May 31, 
2005 at UCSD Medical Center.
This waiver was granted using expedited review procedures.
This study was reviewed by the IRB through expedited review procedure as authorized by 45 
CFR 46.110 and 21 CRF 56.110 and falls under the following research category: (5) Research 
involving materials (data, documents, records, or specimens) that have been collected or will be 
collected solely for nonresearch purposes (such as medical treatment or diagnosis).
Note: All Human Subject research conducted at the VA facility and/or utilizing VA/VMRF 
funds MUST BE APPROVED by the VA Research and Development Committee prior to 
commencing any research. In addition, please ensure that the clinical trial agreement or other 
funding is appropriately in place prior to conducting any research activities. IRB approval does 
not constitute funding approval.
/af
Mamie Gonzalez, Acting Director 
Human Research Protections Program 
Mailcode 0052 Phone: 858-455-5050 
E-mail: hrpp@ucsd.edu
Approval release date: 9/15/2005
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
